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Abstract 
 
Mark Berry:  The Effect of Exercise in the Heat on Circulating Tumor Necrosis Factor-α 
Concentration 
(Under the direction of Dr. Robert G. McMurray)  
 
 To examine the effect of a hot environment on the TNF-α response to exercise, eight 
male subjects (24 ± 1.7 years of age, 1.80 ± 0.06 m, 78.3 ± 6.06 kg, 24.2 ± 1.9 mg/m2, 53.8 ± 
3.7 ml/kg/min; mean ± SD) completed two, 40 min underwater cycling sessions at an 
intensity of 65% VO2peak.  One session took place while submerged in cool water (25.5 ± 
0.02°C) and the other in hot water (38.1 ± 0.06°C).  TNF-α concentration was determined by 
an enzyme-linked immunosorbent assay from blood samples obtained immediately prior to, 
immediately post and two-hours after each exercise session.  The pre-exercise TNF-α 
concentration for the cool and hot trials was 1.76 ± 0.94 and 1.58 ± 1.09, while the post-
exercise concentration was 1.62 ± .81 and 1.54 ± 1.03, and the two hour post-exercise was 
1.75 ± 0.80 and 1.63 ± 1.03, respectively.  No significant differences were found between the 
pre, post-exercise or two hour post-exercise TNF-α concentration within or between the 
exercise bouts (p > 0.05).  No statistically significant relationship was found between change 
in core temperature and change in TNF-α concentration (r = .366; p > 0.05).  The results of 
the present study suggest that forty minutes of moderate-intensity exercise in a cool or hot 
environment does not elevate TNF-α concentration immediately post or two hours post-
exercise 
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Chapter I 
 
Basis for Study 
 
Researchers have found that exercise in the heat can be regarded as a classic physical 
stress, eliciting immunological responses that also occur in reaction to other stressors such as 
sepsis, surgery, or burns (Rhind et al. 2004).  These immunological responses include 
increases in neutrophil concentration, increases in the recruitment of T-cells and natural killer 
cells and a rise in cytokine production (Pederson 2000, Pederson & Toft 2000).  One 
cytokine that may increase in response to both exercise in the heat and other physiological 
stress is tumor necrosis factor-alpha (TNF-α).   
TNF-α is a cytokine primarily produced by activated mononuclear phagocytes in 
response to infection, but can also be produced by T-lymphocytes, neural cells, Kupffer cells 
and endothelial cells (Abbas et al. 1994, Moldoveanu et al. 2001).  Defined as a pro-
inflammatory cytokine, TNF-α is principally involved with the recruitment of neutrophils 
and monocytes to areas of infection in an attempt to increase apoptosis and eliminate 
infectious bacteria (Abbas et al. 1994).  TNF-α can also stimulate a cascade of inflammatory 
reactions involving the expression of other cytokines (Bemelmans et al. 1996).  When 
significant amounts of TNF-α reach the systemic circulation it can take on an endocrine like 
role and stimulate increases in core body temperature (Abbas et al. 1994).    
The evidence related to the TNF-α response to exercise is equivocal; with several 
studies reporting no change in TNF-α following exercise and other studies reporting 
 2 
increased circulating TNF-α levels (Ullum et al. 1994, Rivier et al. 1994).  The proposed 
mechanisms of an exercise induced TNF-α response have not been clearly defined, but 
multiple factors may be involved.  These include, increased cell debris release from injured 
muscles, increased endotoxin release from the gut, and increases in the number of circulating 
leukocytes during exercise (Brenner et al. 1999).  Changes in the mode, intensity and 
duration of exercise can increase the stress placed on the body during exercise and may lead 
to alterations in the mechanisms involved with TNF-α release during to exercise (Rhind et al. 
2004).  Environmental conditions may also affect the mechanisms involved in the TNF-α 
response to exercise (Rhind et al. 2004).  Therefore, all of these factors must be considered 
when examining the degree to which exercise influences TNF-α concentration (Moldoveanu 
et al. 2001).    
Passive exposure to heat without exercise is another form of physiological stress that 
has been shown to affect the circulating TNF-α concentration (Walsh & Whitman 2006).  
Research has shown that exposure to sixty minutes of high ambient temperatures (41.8°C) 
caused an average increase of 600% in circulating TNF-α concentration (Robbins et al. 
1995).  Furthermore, evidence suggests that passive exposure to heat can stimulate peripheral 
monocytes, cause the leakage of endotoxin from the intestine, and may augment endotoxin 
induced TNF-α release; all of which have been proposed as mechanisms leading to increased 
circulating TNF-α concentrations (Walsh & Whitman 2006, Bouchama & Knochel 2002, 
Zeller et al. 2000).  The determining factors related to the TNF-α response to heat include, 
the temperature and length of exposure, and the associated increases in core body 
temperature; with warmer temperatures and longer exposures leading to larger increases in 
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core body temperature and a greater rise in circulating TNF-α concentration (Walsh & 
Whitman 2006).        
In addition to their role as individual stressors, recent research suggests exercise and 
heat exposure combined may work to synergistically affect the mechanisms involved with 
control of the TNF-α response (Walsh & Whitman 2006, Bouchama & Knochel 2002).  
When compared to exercise in a cool environment, exercise in the heat leads to greater 
endotoxin release from the gut and an increased leukocyte response, both of which are 
involved in the mediation of the TNF-α response (Walsh & Whitman 2006, Bouchama & 
Knochel 2002).  Although research has demonstrated the amplification of the mechanisms 
related to the controls of the TNF-α response, attempts to verify this model by examining the 
direct effect of exercise in the heat on circulating TNF-α concentration have been limited 
(Walsh & Whitman 2006). 
Research regarding the TNF-α response to exercise in the heat have produced varying 
results (Rhind et al. 2004, Starkie et al. 2005, Peake et al. 2007).  Some research has shown 
post exercise TNF-α concentration to be significantly higher (200%) than resting values, 
while other studies have shown much smaller increases in circulating TNF-α concentration 
(17%) following exercise in the heat (Starkie et al. 2005, Peake et al. 2007).  The root of 
these divergent results may be related to differences in the methodologies used, including 
variations in the temperature of exposure, and discrepancies in the mode, intensity and 
duration of exercise.  Thus, whether the changes in circulating TNF-α concentration observed 
during exercise in the heat are simply related to the rise in core temperature or whether 
exercise itself intensifies the immune response for a given amount of body heating is still 
unclear (Shephard 1998).    
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Purpose 
 The purpose of this study was to determine whether exercising in the heat affects the 
magnitude of change in circulating TNF-α concentration following a single forty-minute bout 
of exercise.  This was investigated by comparing the circulating levels of TNF-α following 
exercise in a cool environment to the levels of TNF-α following exercise in the heat.   
Research Hypotheses 
 
1. Exercise in the heat will cause an increase in circulating concentrations of TNF-α 
immediately and two-hours post-exercise when compared to resting levels. 
2. Exercise in the heat will elicit greater changes in circulating TNF-α concentration 
immediately and two-hours post-exercise when compared to exercise in a cool 
environment. 
3. A significant positive relationship will exist between changes in TNF-α concentration 
and the changes in core temperature. 
Definition of Terms 
 
1. Cytokine:  Proteins produced by many different cell types that mediate inflammatory 
and immune reactions.  Cytokines are the principle mediators of communication 
between cells in the immune system (Abbas et al. 1994).  
2. Tumor Necrosis Factor-alpha (TNF-α):  A cytokine produced primarily by activated 
mononuclear phagocytes that functions to stimulate the recruitment of neutrophils and 
monocytes to sites of infections (Abbas et al. 2004).     
3. Endotoxin:  A component of cell wall gram negative bacteria that is released from 
dying bacteria and stimulates many innate immune responses (Abbas et al. 2004). 
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4. Phagocyte:  A cell, such as a white blood cell, that engulfs and absorbs waste 
material, harmful microorganisms, or other foreign bodies in the bloodstream and 
tissues (Abbas et al. 2004). 
5. Neutrophil:  The most abundant circulating white blood cell that is recruited to 
inflammatory sites and is capable of phagocytosing and digesting microbes (Abbas et 
al. 2004).  
6. Monocyte:  A type of bone marrow-derived circulating blood cell that is the precursor 
of tissue macrophages (Abbas et al. 2004). 
7. T Cell:  A type of lymphocyte that controls the cell mediated immune response in the 
adaptive immune system (Abbas et al. 2004).   
8. Natural Killer (NK) Cells:  A subset of bone-marrow derived lymphocytes that 
function in innate immune responses to kill microbe-infected cells by direct lytic 
mechanisms (Abbas et al. 2004).  
Assumptions 
 
1. Subjects abstained from additional exercise within the 24 hours prior to each exercise 
session.   
2. Subjects had no prior history of any heat related illnesses.   
3. Subjects were free of infection for the three weeks preceding participation within this 
study.    
4. Subjects were not on anti-inflammatory medications during their participation within 
the study.   
5. Forty-minutes of exercise was sufficient to increase circulating TNF-α concentration. 
6. Exercise in 25°C water resulted in a smaller elevation in core temperature than the 
exercise in the 39°C water.   
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Delimitations 
 
1. Male subjects between the ages of 18 and 40 were recruited from the University of 
North Carolina at Chapel Hill. 
2. Subjects were healthy and physically active, participating in at least thirty minutes of 
exercise at a minimum of four times per week.   
3. Subjects were exposed to 39°C water during the experimental trial and 25°C water for 
the control trial.     
4. Subjects reported for each exercise session after fasting for four hours and having 
abstained from exercise during the preceding 24 hours. 
Limitations 
 
1. Results can be generalized only to healthy, physically active adult males between 18 
and 40 years of age. 
2. Although subjects were assumed to be free of infection during the study, and to have 
been so for three weeks prior to the study, newly developed infections may have been 
unknown to the subjects and could have resulted in the disruption of the baseline 
TNF-α concentration. 
3. Results can be generalized to a hot trial exposure of 39ºC only.   
Significance of Study 
 
 Physical activity in high temperatures is a common practice for individuals involved with 
outdoor exercise training, as well as those whose professional obligations require activity in 
warmer environments (firefighters, military personnel, construction workers, etc.).  In warm 
environments physical activity can be associated with multiple immunological changes, 
including alterations in the circulating levels of the cytokine TNF-α (Rhind el al. 2004, 
Starkie et al. 2005).  TNF-α is a pro-inflammatory cytokine which is expressed in response to 
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infection and physiological stressors such as exercise and passive heat exposure (Ostrowski 
et al. 1999, Walsh & Whitman 2006).  Although TNF-α is a vital component of the immune 
response, high concentrations can lead to pathological states such as sepsis and shock (Rhind 
et al. 2006, Abbas et al. 1994).  Increased circulating concentrations of TNF-α may also 
cause changes in the hypothalamic thermoregulatory set point, causing an increase in core 
body temperature, and have been associated with an increased risk of developing heat related 
illnesses (Walsh & Whitman 2006).  Because high levels of circulating TNF-α may have 
major health consequences, it is important to clearly understand the TNF-α response to 
exercise in the heat.  Unfortunately, previous studies related to this topic have produced 
conflicting results, and the TNF-α response to exercise in the heat is not clearly defined 
(Rhind et al. 2004, Starkie et al. 2005, Peake et al. 2007). 
 Some evidence suggests that exercise in the heat may lead to larger increases in 
circulating TNF-α concentration when compared to exercise in a cool environment, but 
results have varied. For example, researchers reported large increases in TNF-α concentration 
(90% and 200%) immediately after exercise in a warm environment, while others have 
indicated smaller TNF-α increases (17%) (Rhind et al. 2004, Starkie et al. 2005, Peake et al. 
2007).  Because there have been discrepancies in previous reports, this study was designed to 
investigate the effect of exercise in the heat on circulating TNF-α levels.  This study will help 
clarify the role of environment temperature on the TNF-α response to exercise.  Collectively, 
the results of this study may help to determine appropriate environmental conditions for 
which it is safe for physical activity to occur without negatively affecting the immune 
system. 
  
 
 
 
Chapter II 
 
Review of Literature 
 
Tumor necrosis factor-α (TNF-α) is classified as a pro-inflammatory cytokine and is 
principally involved with increasing the recruitment of neutrophils and monocytes to areas of 
infection (Abbas et al. 1994, Bemelmans et al. 1996).  TNF-α can be produced by activated 
mononuclear phagocytes, T-lymphocytes, neural cells, Kupffer cells and endothelial cells 
(Abbas et al. 1994, Moldoveanu et al. 2001).  In addition to the heightened concentration 
associated with infection, increases in TNF-α production are also be seen in response to 
physiological stressors such as sepsis, surgery, burns, passive heat exposure and exercise.   
 Recently there has been an increase in the amount of literature concerning the 
combined effect of heat exposure and exercise on the TNF-α response (Rhind et al. 2004, 
Starkie et al. 2005, Peake et al. 2007).  However, conflicting results have been found in many 
of the studies, making the direction and magnitude of the TNF-α response difficult to 
understand.  The inconsistencies in the literature may stem from discrepancies in the 
methodology used, including variations in environmental conditions and differences in the 
mode, intensity and duration of exercise.  This review of literature will focus on how 
environmental conditions may be a key factor within exercise bouts which influence the 
TNF-α response.  The first section will provide the basic information concerning cytokines, 
with the review focusing on TNF-α.  Subsequent sections will highlight the TNF-α response 
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to exercise, the TNF-α response to passive heat exposure, and lastly, the TNF-α response to 
exercise in the heat.   
Cytokines 
 Cytokines are one of the key mediators of the immune response, and can be produced 
not only from activated macrophages, but also from many other cells within the body (Abbas 
et al. 1994).  Produced during the effector phase of natural and specific immunity, cytokines 
serve to regulate the intensity and length of the immune response by inhibiting or stimulating 
many of the cells involved within immunity (Abbas et al. 1994).  In general, cytokines are 
water soluble proteins and glycoproteins, with a mass between 8 and 30 kDa (Abbas et al. 
1994).  Depending on their role within the immune systems, cytokines are classified as either 
pro- or anti- inflammatory (Abbas et al. 1994).  Pro-inflammatory cytokines increase the 
recruitment and activation of leukocytes, enhancing inflammation, while anti-inflammatory 
cytokines hinder inflammatory responses by inhibiting both the production and the actions of 
the pro-inflammatory cytokines (Abbas et al. 1994).  Overall, it is the cytokines ability to act 
in both an autocrine and paracrine like fashion and their pleiotopic qualities which allow 
them to have a profound overall effect on the immune response.  One such cytokine with 
many biological actions that can have a profound effect on the immune response is TNF-α.  
Table 1 presents a selection of various cytokines and a summary of their roles.  
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Table 1. Selected cytokines and their biological effects (adapted from Abbas et al. 1994). 
  Abbreviations:  
  MHC: Major histocompatibility complex NK cells: Natural killer cells 
  T cells: T lymphocytes    B cells: B lymphocytes    
Cytokine Principle 
Source 
Target Cell Biological Effects 
Endothelial 
cells  
Activation 
Hypothalamus Fever 
Interleukin (IL)-1 Macrophages, 
endothelial 
cells, 
epithelial 
cells 
Liver Synthesis of acute phase 
proteins 
T cells  
 
Proliferation, increased 
cytokine synthesis, apoptosis 
NK cells  Proliferation, activation 
Interleukin (IL)-2 T cells  
B cells  Proliferation, anti-body 
synthesis  
B cells  Isotype switching to 
immunoglobulin E 
T cells Cell differentiation, 
proliferation 
Interleukin (IL)-4  CD4+ T cells, 
mast cells 
Mast cells  Proliferation  
Eosinophils  Activation, increased 
production 
Interleukin (IL)-5  CD4+ T cells  
B cells  Proliferation 
Liver Synthesis of acute phase 
proteins 
Interleukin (IL)-6  Monocytes, 
macrophages, 
endothelial 
cells, T cells   
B cells Proliferation of anti-body 
producing cells 
  
Macrophages Inhibition of IL-12 production, 
expression of co-stimulators 
and class II MHC molecules  
Interleukin (IL)-10  Macrophages,  
T cells  
B cells  Proliferation 
IFN-γ synthesis, increased 
cytolytic activity  
Interleukin (IL)-12 Macrophages, 
dendritic cells  
NK Cells  
 
T cells  
 Cell differentiation  
Macrophages  
 
Activation (increased microbial 
functions) 
Endothelial 
cells  
Activation 
Interferon (IFN)-γ T cells, NK 
cells 
Various cells  
 
Increased expression of class I 
and II MHC molecules, 
increased antigen processing 
and presentation to T-cells   
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TNF-α 
 TNF-α is a pro-inflammatory cytokine produced by mononuclear phagocytes, T-
lymphocytes, neural cells, Kupffer cells and endothelial cells (Abbas et al. 1994).  Initially 
discovered during the 19th century, TNF-α has a large range of effects on a variety of cell 
types (Bemelmans et al. 1996).  The overall effects of TNF-α may be beneficial or 
detrimental depending upon its concentration, duration of cell exposure and the presence of 
other immune system mediators that may act in concert with TNF-α (Camussi et al. 1991).       
One way in which TNF-α benefits the immune system is through its ability to 
increase the recruitment of neutrophils and monocytes to areas of infection (Abbas et al. 
1994).  Immune cell recruitment increases in an attempt to eliminate infectious bacteria and 
can be brought on via multiple pathways (Abbas et al. 1994).  TNF-α is able to increase 
immune cell recruitment via its effect on endothelial cells, as TNF-α stimulation causes 
endothelial cells to express adhesion molecules (Abbas et al. 1994).  Enhanced expression of 
adhesion molecules from the endothelial cells permits neutrophils, monocytes and 
lymphocytes to bind to the endothelial surface with greater efficiency (Abbas et al. 1994, 
Camussi et al. 1991).  A second pathway through which TNF-α is able to influence cell 
recruitment is through the stimulation of both endothelial cells and macrophages (Abbas et 
al. 1994).  TNF-α stimulation of endothelial cells and macrophages enhances the secretion of 
chemokines that work to increase the total leukocyte recruitment to areas of infection (Abbas 
et al. 1994).  A third way in which TNF-α can increase immune cell recruitment to areas of 
infection involves its role of in production of additional cytokines (Abbas et al. 1994).  TNF-
α increases the production of other cytokines, for example Interleukin-1, with functions 
similar to its own.  An increased production of similar cytokines allows the immune 
 12 
processes that TNF-α itself is involved with to be amplified (Abbas et al. 1994).  By 
increasing the production of cytokines that also influence immune cell recruitment, TNF-α is 
able to further influence immune cell recruitment.  The overall ability of TNF-α to increase 
recruitment of neutrophils and monocytes via the multiple pathways is an advantageous and 
vital immune response (Abbas et al. 1994).  The importance of recruitment by TNF-α is 
supported by the finding that inadequate amounts of the cytokine have been associated with a 
diminished ability to contain infections (Abbas et al. 1994).   
TNF-α is also involved with the coordination of tissue remodeling, as research has 
shown that TNF-α influences both cell growth and cell breakdown (Vicek et al. 1986, 
Bertolini et al. 1986, Saklatvala 1986).  TNF-α is capable of stimulating fibroblast 
production, a cell type directly utilized within tissue synthesis and healing, and mesenchymal 
cell production, a stem cell involved with tissue synthesis that can give rise to a variety of 
other cell types (Vicek et al. 1986).  TNF-α is also able to affect cell growth by increasing the 
production of other cytokines that are involved with increased cell proliferation (Vicek et al. 
1986).  In contrast to cell growth, evidence has also suggested that TNF-α can be involved in 
the increased breakdown in tissues such as of both bone and cartilage (Bertolini et al. 1986, 
Saklatvala 1986).  The proposed mechanism through which bone breakdown is increased is 
related to the capacity of TNF-α to inhibit collagen synthesis, and decrease the amount of 
alkaline phosphate, which is an enzymatic marker of new bone formation (Bertolini et al. 
1986).  Cartilage growth is affected through the inhibition of proteoglycan synthesis, which 
is the component of cartilage tissue that allows for the resistance of compression during load 
bearing (Saklatvala 1986).  The ability of TNF-α to stimulate both tissue growth and 
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breakdown provides evidence that it may be an important factor in the regulation of tissue 
remodeling.   
A negative function of TNF-α relates to its involvement in the progression of heat 
illnesses (Walsh & Whitman 2006).  TNF-α raises prostaglandin production within the 
hypothalamus, which increases the thermoregulatory set point (Abbas et al. 1994, Walsh & 
Whitman 2006).  As the set point increases, the core body temperature at which sweating 
occurs rises, diminishing the body’s ability to dissipate heat effectively (Walsh & Whitman 
2006).  TNF-α may also increase vascular permeability, which can amplify plasma volume 
losses (Lim & Mackinnon 2006).  Losses in plasma volume may decrease the amount of 
blood volume that can be sent to the skin, and this may further compromise the ability of the 
body to efficiently release heat (Lim & Mackinnon 2006).  As the body losses the ability to 
dissipate heat effectively core temperature rises rapidly and the risk of developing heat 
related illnesses is increased.  Past research has suggested that a strong relationship exists 
between circulating TNF-α concentration and the severity of heat stroke, emphasizing the 
role that TNF-α may have in the development of heat related illnesses (Lim & Mackinnon 
2006). 
TNF-α also acts on hepatocytes within the liver to increase the production of acute 
phase plasma proteins (Bauman & Gauldie 1994).  The acute phase response is an immediate 
set of reactions that are induced in an effort to prevent ongoing tissue damage, to destroy 
infected organisms and to activate repair processes (Bauman & Gauldie 1994).  It has been 
found that TNF-α can enhance the expression of α-acid glycoprotein, serum amyloid A, C-
reactive protein, complement component C3 and haptoglobin, all of which are major 
components of the acute phase response (Bauman & Gauldie 1994).  The entire acute phase 
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reactive process is also known as inflammation.  Therefore, it can be inferred that through its 
involvement in hepatic acute phase protein expression, TNF-α can lead to the progression of 
the body’s inflammatory response.     
Increases in the circulating concentration of TNF-α also affect the coagulation 
properties within the endothelium of blood vessels (Abbas et al. 1994).  TNF-α stimulates the 
expression of tissue factor, a potent activator of coagulation, and inhibits the production of 
thrombomodulin, an inhibitor of coagulation (Abbas et al. 1994).  These changes in 
coagulation can lead to the development of an intravascular thrombus, causing a decrease in 
blood flow to the area in which the thrombus has formed (Abbas et al. 1994).  The capacity 
of TNF-α to affect coagulation properties is what actually allows TNF-α to cause the necrosis 
of tumor cells, as changes in coagulation lead to decreases in blood flow to the tumor and 
ultimately cause tumor cell death (Abbas et al. 1994). 
Prolonged high levels of TNF-α production may provoke cachexia, a state 
characterized by the wasting of muscle and fat cells (Abbas et al. 1994).  It has been found 
that adipocytes and skeletal myocytes incubated with TNF-α increase both lipolysis and 
glycogenolysis processes, initiating a catabolic environment (Torti et al. 1985, Lee et al. 
1987).  Evidence has also suggested that high concentrations of TNF-α can increase the rate 
of whole body energy expenditure, protein turnover, and cause losses in body mass similar to 
metabolic alterations seen in association with chronic infections and critical illnesses (Tracey 
et al. 1988).   
The systemic release of TNF-α is also involved in the progression of symptoms 
related to endotoxic shock (Camussi et al. 1991).  Large sustained increases in TNF-α 
concentration are associated with the inhibition myocardial contractility and the loss of 
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vascular smooth muscle tone (Camussi et al. 1991).  These cardiovascular changes can cause 
substantial decreases in blood pressure and further the development of shock (Camussi et al. 
1991). 
 Although TNF-α is a vital component of a healthy immune response, evidence has 
shown that increases in the circulating concentration can also lead to a variety of health 
problems (Abbas et al. 1994).  Examples of pathological states associated with an increased 
concentration of TNF-α include sepsis and shock (Rhind et al. 2004, Abbas et al. 1994).  The 
collective evidence supporting the concept that TNF-α can contribute to health related issues 
may be of clinical importance in situations in which large increases in TNF-α are seen.    
TNF-α Response to Exercise 
 Exercise is a form of physiological stress that can influence TNF-α concentration 
(Moldoveanu et al. 2001, Ostrowski et al. 1999).  The literature related to the TNF-α 
response to acute and chronic exercise will be reviewed separately, as the two forms of 
exercise can affect the circulating concentration of TNF-α in different ways.   
The evidence concerning the TNF-α response to acute exercise is equivocal.  In those 
studies that have shown significant results the direction and magnitude of the change in TNF-
α may be influenced by the mode, intensity and duration of the exercise (Rivier et al. 2007, 
Febbraio et al. 2003).  Ostrowski et al. (1999) examined the effect of a marathon run (26.2 
miles) on the circulating TNF-α concentration in ten healthy male subjects.  During the 
marathon run the subjects were exercising at an intensity of 60-80% of their VO2max (Sjodin 
& Svedenhag 1985).  TNF-α measurements were made on blood samples taken one week 
prior to the race (baseline measurement), immediately after the race, and every 30 minutes 
during the four hour period directly following the marathon.  The TNF-α concentration 
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peaked immediately after exercise (a two fold increase from the baseline measurement) then 
slowly decreased during the four hours after exercise.  The circulating concentration of TNF-
α stayed significantly elevated over the baseline concentration for three full hours after the 
marathon had been completed.    
 Moldoveanu et al. (2000) evaluated the TNF-α response to three hours of exercise at 
60-65% of VO2peak in ten healthy male subjects.  Subjects exercised for one hour on a cycle, 
then performed one hour of treadmill running, and finished by returning back to the cycle for 
one hour.  When compared to resting baseline measurements, circulating TNF-α was 
significantly elevated by 20% and 90% at 60 and 180 minutes of exercise, respectively.  At 
the one hour mark of recovery the TNF-α concentration began to decrease from the peak 
values observed, but remained elevated over resting values for 24 hours after the exercise 
was concluded.    
The effect of three different modes of exercise on the circulating TNF-α 
concentration was assessed by Brenner et al (1999).  The exercise modes consisted of high 
intensity cycling (average intensity of 90% VO2max) for five minutes, a standard circuit 
training routine (five different types of weight lifting exercises), and cycling at 60-65% of 
VO2max for two hours.  The only exercise mode to cause a significant change in the 
circulating TNF-α concentration was the continuous cycling, which saw an increase (~50%) 
in TNF-α concentration immediately post exercise when compared to baseline values.  
Vassilakopoulos et al. (1998) studied the effect of antioxidant supplementation on the 
TNF-α response to 45 minutes of exercise at 70% VO2max.  Ten healthy male subjects 
performed two exercise sessions, one prior to 60 days of antioxidant supplementation 
(vitamins A, E and C for 60 days, allopurinol for 15 days, and N-acetylcysteine for 3 days) 
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and one directly after supplementation.  Blood samples were collected at rest, immediately 
after exercise, and at 30 and 120 minutes into recovery.  The TNF-α concentration was 
significantly elevated (60%) over resting values immediately after exercise in the non-
supplementation trial, but not the supplementation trial.  As the TNF-α response to exercise 
was nearly abolished after antioxidant supplementation; these results suggest that oxidative 
stress may have a role in the regulation of TNF-α expression during an acute bout of 
exercise.   
Although the results of several studies suggest that the circulating concentration of 
TNF-α increases in response to acute exercise, a number of studies have also found no 
change in TNF-α concentration.  Febbraio et al. (2003) investigated the effect of cycling at an 
intensity of 60% of VO2peak for 25 minutes on TNF-α concentration in both healthy subjects 
and patients with type II diabetes.  Blood samples were taken at rest and immediately before 
the cessation of cycling.  No change in circulating TNF-α concentration was found following 
exercise in either the healthy subject or the type II diabetes patients.  The lack of a significant 
TNF-α response may be due to the short duration of exercise that was used within this study, 
as the studies with significant findings employed longer exercise bouts.  The 25 minutes of 
exercise utilized within this study may not have placed enough stress on the body to 
substantially affect the TNF-α response.      
 Likewise, Rivier et al. (1994) found no significant increase in TNF-α concentration in 
response to acute exercise.  Sixteen healthy male subjects completed incremental exercise 
tests, and had blood drawn at rest, immediately post exercise, as well as 20 minutes into 
recovery.  While it was found that TNF-α increased slightly in response to exercise, the 
change was not significant when compared to resting levels.  All of the studies with 
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significant findings used continuous exercise protocols, while this study employed an 
incremental test.  The differences in methodology may explain why exercise had no 
significant effect on the TNF-α response within this study.       
 Ullum et al. (1994) failed to detect a significant increase in the circulating TNF-α 
concentration in response to one hour of cycling at 75% VO2max.  Blood samples were taken 
from seventeen healthy male subjects at rest, during the last minutes of exercise, and two and 
four-hours post exercise.  No increase in the circulating concentration of TNF-α was 
observed at any point during or post exercise.  The author suggested that the lack of a 
significant finding could be due to the sensitivity of assay used, as the TNF-α concentrations 
were below detectable in many of the subject before the exercise began.     
 In summary, the collective literature concerning the TNF-α response to acute exercise 
has produced varying results.  There have been multiple studies suggesting either increases or 
no change in the circulating TNF-α following acute exercise and during recovery (Ostrowski 
et al. 1999, Moldoveanu et al. 2000, Rivier et al. 1994, Ullum et al. 1994).  As large 
variations in the in the mode, intensity, and duration of the exercise are present within these 
studies, these factors may greatly affect the TNF-α response to acute exercise.  It may be the 
case that a certain intensity or duration threshold must be met before any significant change 
in the circulating TNF-α concentration can occur in response to acute exercise.  In general, 
the studies which involved exercise intensities greater than 65% or a duration longer than one 
hour saw significant increases in the TNF-α concentration, while the studies that used shorter 
and less intense exercise bouts saw no significant change.       
Similar to discrepancies reported within the results related to acute exercise, the effect 
of chronic exercise on the TNF-α response is not clearly defined.  Although it has been 
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hypothesized that regular exercise may suppress resting TNF-α concentration, the results of 
the existing literature differ as to the effectiveness of the TNF-α suppression (Horne et al. 
1997, Stewart et al. 2007, Adamopoulos et al. 2002).  The divergent results may be due to 
variations in the populations used within each study; as many of the studies displaying 
decreases in resting TNF-α level in response to chronic exercise have examined diseased or 
overweight populations (Horne et al. 1997, Adamopoulos et al. 2002).  Variations in the 
results may also stem from differences in the exercise intensities used within each study 
(Stewart et al. 2007, Straczkowski et al. 2001). 
 Horne et al. (1997) investigated the TNF-α response within forty five subjects (27-
male, 18-females) involved in four different prolonged exercise training programs.  The 
twelve week programs consisted of individual endurance and resistance training programs, a 
combined endurance and resistance program and a control group.  An effort was made to 
equally distribute male and females into each group.  The endurance program consisted of 30 
minutes of continuous cycling at the subject’s ventilatory threshold for three days a week.  
The resistance training program involved three days a week of both machine and free weight 
training.  The combined resistance and endurance program united the two individual 
programs for six days a week of exercise.  The control group performed no exercise.  Blood 
samples were taken prior to the initiation of, six weeks into, and at the end of the twelve 
week exercise program.  The samples were taken after 48-72 hours of no training and in 
between the hours of 4pm and 6pm.  All subjects had baseline TNF-α measurements that fell 
within the normal range (3-20 pg/ml).  With the exception of one group (the females in the 
endurance training group), no significant changes in resting TNF-α concentration was 
observed in the groups after the exercise program.  The results of this study may indicate that 
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chronic endurance and resistance training programs have a limited ability to suppress resting 
TNF-α concentration in healthy populations.   
Stewart et al. (2007) observed no change in resting the TNF-α concentration in 
response to chronic exercise training.  A group of 29 younger adults (18-35 years old) and a 
group of 31 older adults (65-85 years old) were recruited for this study, with relatively equal 
numbers of males and females being used.  Subjects were asked to perform a twelve week 
combined endurance and resistance exercise training program.  The program entailed three 
days a week of exercise, with each day consisting of 20 minutes of endurance exercise at an 
intensity of 70-80% heart rate reserve and two sets of eight different resistance exercises.  
Blood samples were taken after eight to ten hours of fasting between the hours of 6am-8am, 
and occurred before and after the twelve week exercise intervention.  Normal resting TNF-α 
levels (3-20 pg/ml) were seen within all groups.  No significant change in resting TNF-α 
concentration was observed in either the young or old adults following the twelve week 
program.  Similar to the Horne et al. study, these findings may suggest that chronic exercise 
is not able to significantly alter resting TNF-α concentration in healthy subjects. 
 In contrast to the two studies involving healthy subjects, there has also been research 
involving diseased and overweight subjects that indicates chronic exercise can significantly 
influence resting TNF-α concentration (Adamopoulos et al. 2002, Straczkowski et al. 2001).  
In a study conducted by Adamopoulos et al. (2002), 24 patients with moderate to severe 
congestive heart failure (CHF) and 20 healthy control subjects performed a twelve week 
home-based bicycle exercise training program.  The program consisted of 30 minutes of 
cycling five days a week.  Subjects were asked to continually monitor their heart rate during 
exercise and to keep it within 60-80% of their previously determined maximal heart rate.  
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Blood samples were obtained from the subjects at baseline, after the twelve weeks of 
training, and during the detraining stage when subjects were no longer exercising.  Although 
both groups fell within the normal resting TNF-α range at baseline (3-20 pg/ml), the CHF 
group began the training program with a significantly higher TNF-α concentration than the 
control group (7.4 ± 0.8 pg/ml vs. 3.6 ± 0.2 pg/ml).  A significant decease in resting TNF-a 
concentration was observed in the CHF patients, but not the healthy subjects, after the twelve 
weeks of training.  The findings also indicated that during the detraining period the resting 
TNF-α concentration of the CHF subjects began to return to near baseline levels, further 
emphasizing the finding that exercise may have had a role in suppressing resting TNF-α in 
the CHF patients.   
 Straczkowski et al. (2001) examined the effect of a twelve week exercise program on 
the resting TNF-α concentration in obese women (BMI >30 kg/m2) with normal fasting 
glucose (NGT), and obese women with impaired fasting glucose tolerance (IGT).  A group of 
women with a BMI < 25 kg/m2 and normal fasting glucose was used as a control.  All groups 
contained eight subjects.  The endurance exercise program involved the subjects cycling for 
thirty minutes at an intensity equal to 70% of their maximal heart rate five days a week.  
Blood samples were obtained prior to the initiation and after the exercise program was 
completed.  Samples were taken at 8 am after a twelve hour fast, and 48 hours after the last 
bout of exercise.  While the baseline TNF-α measurements of all the groups fell within the 
normal range (3-20 pg/ml), the resting concentrations of the obese (IGT and NGT) groups 
were significantly higher then the levels observed in the control group (6.59 ± 2.31 pg/ml and 
3.88 ± 0.49 pg/ml vs. 3.27 ± 0.39 pg/ml).  After the twelve week exercise intervention there 
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was a significant decrease in the resting TNF-α concentration in both obese groups, but not 
the control group.       
The findings of the studies involving chronic exercise in unhealthy populations 
contradict the results that were reported in studies investigating healthy subjects.  In the 
studies using the healthy subjects, it seems likely that the subjects would have already had a 
low resting concentration of TNF-α, which may not have been able to be decreased any 
further by the exercise program.  This may have been the case in the studies involving 
healthy populations, as all baseline TNF-α measurements fell with a normal range (3-20 
pg/ml).  Therefore, it is reasonable that these studies found that chronic exercise had no 
effect on resting TNF-α level.  In contrast, the persistent activation of the immune system 
associated with CHF and obesity may raise the resting TNF-α concentration to a high enough 
point where chronic exercise can influence the TNF-α level.  This idea is supported by the 
findings of the Adamopoulos et al. (2002) and the Straczkowski et al (2001) studies, which 
observed significantly higher baseline TNF-α concentrations in the CHF and obese subjects 
when compared to healthy controls.  Discrepancies in the results may also stem from 
differences in the intensities of exercise used with the healthy and unhealthy populations.  It 
appears as though the studies of chronic exercise involving higher exercise intensities 
(ventilatory threshold and 70-80% of HRR), seen in association with the healthy populations, 
had no effect on the resting TNF-α concentration.  Conversely, the studies of chronic 
exercise utilizing lower intensities (60-80% of heart rate max) effectively lowered resting 
TNF-α concentration.  The possibility of a heightened immune response combined with the 
differences in the exercise protocols used may explain why chronic exercise caused a 
decrease in resting the TNF-α concentration in the unhealthy, but not the healthy populations.    
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TNF-α Response to Passive Heat Exposure 
 Passive exposure to heat is another form of physiological stress that may alter the 
circulating TNF-α concentration (Walsh & Whitman 2006).  Similar to the responses 
observed with acute and chronic exercise, results relating to the effect of passive heat 
exposure on TNF-α concentration have varied.  When determining the effect that heat 
exposure has on the TNF-α response multiple factors must be taken into account, including 
the environmental temperature and length of the exposure, as well as the core temperature 
increases that are associated with the heat exposure (Rivier et al. 1994).  Warmer 
environmental temperatures and longer exposure are associated with larger increases in core 
temperature, which may elicit greater increases in the circulating TNF-α concentration 
(Rivier et al. 1994).     
 Robins et al. (1995) investigated the effect of whole body hyperthermia, induced by 
passive heat exposure, on the circulating TNF-α concentration.  Subjects were exposed to a 
temperature of 41.8°C for 60 minutes.  Blood samples were obtained fifteen minutes before 
heat exposure, during exposure, and 2.5, 5.5 and 23.5 hours after exposure.  It was found that 
a significant increase in TNF-α occurred immediately post heat exposure for a portion (43%) 
of the subjects.  Blood analysis for the other subjects revealed no detectable concentration of 
TNF-α prior to or after heat exposure.  The researchers hypothesized that the inability to 
detect TNF-α in some of the samples was related to the sensitivity of the assay used and the 
biological differences between the subjects. 
Likewise, D’ Oleire et al. (1995) observed an increase in the TNF-α concentration in 
response to heat exposure in several (22%) of the subject examined.  Blood samples were 
obtained from nine subjects fifteen minutes prior to and immediately after one hour of heat 
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exposure (41.8°C).  Samples were also taken three hours, six hours and twenty-four hours 
post exposure in order to track the prolonged progress of the TNF-α response.  A significant 
(600%) increase in TNF-α was observed in two of the nine subjects, with peak concentrations 
occurring three hours after the heat exposure.  Similar to the Robins et al. study, the inability 
to determine a detectable TNF-α concentration in a portion of the blood samples before and 
after the heat exposure was attributed to the sensitivity of the assay used, as well as the 
biological differences within each subject.  It may be the case the local production of TNF-α 
increased in response to the heat exposure, but that the increase was not large enough to 
cause a systemic increase in TNF-α concentration that would be picked up by that assay 
used.   
Using a different protocol, Bouchama et al. (1991) observed significantly elevated 
TNF-α levels in seventeen patients already experiencing non-exertional (classic) heatstroke.  
All patients involved had a rectal temperature greater than 40.1°C upon admission to the 
hospital.  Samples were taken from patients immediately after admission and after a cooling 
treatment had been administered.  Results indicated that the circulating TNF-α concentration 
was significantly elevated in all subjects experiencing heatstroke when compared to control 
subjects (199 ± 25 pg/ml vs. (31.4 ± 8.4 pg/ml).  TNF-α concentration decreased in response 
to the cooling treatments, and the corresponding drop in rectal temperature, but still remained 
above the levels observed within the control subjects. 
 Contradicting the previous studies, Dubose et al. (2002) observed no significant 
change in the circulating TNF-α concentration in response to passive heat exposure.  Blood 
samples were taken from ten male subjects and exposed to heat alone (42.4°C), endotoxin 
alone, and heat plus endotoxin.  Endotoxin is a component of cell wall gram negative 
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bacteria that stimulates TNF-α production and naturally increases in concentration in 
response to heat exposure (Bouchama & Knochel 2002).  After the exposures, a significant 
increase (~300%) in TNF-α concentration occurred in response to the combination of heat 
and endotoxin, but not the individual exposures.  These results suggest that exposure to heat 
alone may not be enough to cause a change in the circulating concentration of TNF-α.  It may 
be that a concomitant increase in endotoxin is needed with the heat exposure before the TNF-
α concentration can be effected.   
 In summary, the results of previously conducted research suggest that the circulating 
TNF-α concentration may or may not increase in response to passive heat exposure. In 
general, it appears that exposure to high environmental temperatures may lead to a greater 
TNF-α response, but the exact magnitude and direction of response is not clearly defined.  
Discrepancies in the results of previously conducted studies may stem from differences in the 
temperature and duration of heat exposure, as well as the exposure techniques 
(environmental chamber vs. water immersion) that were used.    
TNF-α Response to Exercise in the Heat 
 In addition to their roles as individual physiological stressors, research suggests that 
when combined, exercise and heat exposure may additively affect the TNF-α response.  
Similar to the studies investigating exercise and passive heat exposure separately, a variety of 
exercise and heat methodologies have been used to examine the combined effect of the 
stressors.  Due to the differences within these studies, the extent to which exercise and heat 
combined influence the TNF-α response has not been clearly defined.   
 A significant increase in the circulating TNF-α concentration in response to exercise 
in the heat can be seen a study conducted by Peake et al (2007).  This study involved ten 
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trained male subjects and two separate exercise trials.  Subjects were exposed to 
environmental temperatures of 18°C and 32°C during the two exercise trials.  The 
temperature was controlled through the use of an environmental chamber, and each exercise 
trial consisted of 90 minutes of steady state cycling (60% VO2max), directly followed by a 
16.1 km performance time trial.  Blood samples were taken prior to exercise, after the 90 
minutes of steady state exercise, immediately after the time trial, and 45 and 90 minutes into 
recovery.  Rectal temperature was measured continuously during the exercise and recovery, 
with the highest temperatures (~39.0°C) occurring at the end of exercise in the 32°C heat.  
The circulating TNF-α concentration significantly increased over baseline levels after 
exercise in heat (32°C), but not the cold (18°C).  Results also indicated that the TNF-α 
concentration was significantly higher (17%) at minute 90 during exercise in the 32°C heat 
when compared exercise in the 18°C cold (1.5 ± 0.2 pg/ml vs. 1.2 ± 0.1 pg/ml).         
Rhind et al. (2004) observed an increased TNF-α response during exercise in the heat 
(39°C) when compared exercise in a cold environment (18°C).  The exercise trials entailed 
ten healthy male subjects cycling at 65% of their previously established VO2peak for forty-
minutes while immersed in water up to the chest.  Blood samples were taken immediately 
before the exercise began, after 20 and 40 minutes of exercise, and 30 and 120 minutes into 
recovery.  Rectal temperature was continuously monitored during exercise and recovery 
periods, with peak temperatures (39.1 ± 0.2° C) being reached immediately post exercise in 
the hot environment.  A significant increase in the circulating TNF-α concentration was 
observed immediately after exercise in the hot, but not the cold environment (~1.4 pg/ml vs. 
0.1 pg/ml).  The concentration of TNF-α began to increase after twenty minutes of exercise 
in the heat, and peaked above resting levels by the end of exercise (>90%).  Results also 
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showed that the increase in the TNF-α concentration was positively correlated with the rise in 
rectal temperature (r = 0.493).            
 Starkie et al. (2005) investigated the TNF-α response to 90 minutes of exercise when 
subjects were exposed to 15°C and 35°C.  The exercise trials involved seven endurance 
trained males cycling at 70% of VO2peak.  Rectal temperature and blood samples were 
collected prior to exercise, at fifteen minute intervals during exercise, and two hours post 
exercise.  Rectal temperature was significantly elevated between minutes 65-90 during 
exercise in the heat when compared to the cooler environment (~39°C vs. 38°C).  Peak rectal 
temperatures (>39.0°C) occurred 90 minutes into hot exercise trial.  Circulating TNF-α 
concentration peaked immediately post exercise in both trials, but was significantly higher in 
the hot exercise trial than during the cooler trial (~3.3 pg/ml vs. 2.1 pg/ml). 
 Similar to the studies related to exercise alone and heat, the literature concerning the 
TNF-α response to exercise in the heat has produced a wide range of results.  Although 
research has established that these stressors can influence the mechanisms involved with the 
control of the TNF-α response, attempts to confirm this model by examining the direct effect 
of exercise in the heat on the circulating TNF-α concentration have been limited (Walsh & 
Whitman 2006).  When the research related to this topic is reviewed, differences in the 
magnitude of change in the circulating TNF-α concentration caused by exercise are evident 
(Rhind et al. 2004, Starkie et al. 2005, Peake et al. 2007).  The differing results may be 
related to discrepancies in the methodologies used, including variations in environmental 
conditions, and in the mode, intensity and duration of the exercise bouts.  A comparison of 
the methods and results of the relating to exercise in the heat and the TNF-α response can be 
seen in Table 2.   
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Table 2. A comparison of the studies examining the effect of a exercise in the heat on resting 
TNF-α concentration.   
   1 = Chamber;  2 = Water                           * Indicates significant difference between trials 
 
Summary 
 
 When reviewing the literature related to acute exercise it appears that both exercise 
intensity and duration have an affect on the ability of exercise to influence the TNF-α 
response.  In general, increases in the TNF-α response to acute exercise appear to be greater 
when the exercise bout is continuous and greater than 30 minutes in duration, and when the 
intensity of the exercise exceeds 60% of VO2peak.  This relationship may be related to a 
threshold effect, in that a certain, but presently unknown, amount of stress must be placed on 
the body by the exercise before the mechanisms controlling the TNF-α response can be 
affected.  Similarly, there have been variations in the results concerning the capacity of 
chronic exercise to influence resting TNF-α concentration.  When the chronic exercise 
studies are examined, it becomes evident that the population used (healthy vs. unhealthy), as 
well as the exercise intensity, may be critical factors related to the ability of chronic exercise 
Researcher Methods Results 
Peake et al (2007) 1)  90 min @ 60% 
VO2peak 
18°C (C) 
32°C (H) 
 
Peak Tre= 38.1°C (C) 
38.8°C (H)* 
Post Exercise: 17% > in H 
 
 
Rhind et al. (2004) 
 
2)  40 min @ 65% 
VO2max 
18°C H2O (C) 
39°C H2O (H) 
 
Peak Tre = 37.6°C (C) 
39.3°C (H)* 
Post Exercise: 
0.1 pg/ml (C) 
1.4 pg/ml (H)* 
 
 
Starkie et al. (2005) 
 
 
1) 90 min @ 70% VO2peak 
15°C H2O (C) 
35°C H2O (H) 
 
Peak Tre = ~ 38.0° C (C) 
~ 39.0° C (H)* 
Post Exercise: 
2.1 pg/ml (C) 
3.3 pg/ml (H)* 
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to influence the resting TNF-α response.  Discrepancies are also observed in the results of 
studies concerning passive heat exposure and the TNF-α response.  Much like the exercise 
studies, the direction and magnitude of the TNF-α response to heat exposure is unclear.  The 
findings suggest that warmer temperatures and longer exposures lead to greater increases in 
core temperature, and a larger rise in the circulating TNF-α concentration, but this finding is 
not uniform across the studies.  Differences in the length and temperature of heat exposure, 
as well as disparities in the method of heating, may work to explain some of the variation in 
the results concerning passive heat exposure.  The results of the studies investigating the 
TNF-α response to exercise in the heat also differ in the degree to which they suggest the 
physiological stressors can affect circulating TNF-α concentration.  The divergent results 
may be due to differences in the length and temperature of the heat exposure and in the 
duration and intensity of the exercise used within the studies.     
 Based on these discrepancies, the proposed study will examine the effect of exercise 
in the heat on the circulating concentration of TNF-α by using two, forty-minute cycling 
bouts at an intensity of 65% of VO2peak.  One exercise trial will take place with the subjects 
cycling while immersed in 25°C water, and the other will involve the subjects cycling while 
immersed in 39°C water.  The aim of the present study is to evaluate the direction and 
magnitude of the TNF-α response to exercise in the heat.  A secondary goal of the study it to 
examine the relationship between increases in core temperature associated with exercise in 
the heat and changes in the circulating concentration of TNF-α.     
  
 
 
 
Chapter  III 
 
Methodology 
 
 The purpose of this study was to determine the effect of exercise in the heat on the 
circulating concentration of tumor necrosis factor-α (TNF-α).  This purpose was achieved by 
comparing changes in TNF-α concentration following exercise in a cool environment with 
the changes following exercise in the heat.  This chapter explains the methodology by 
describing the subjects and instrumentation that will be used during the investigation, as well 
as by detailing the protocol and physiological data testing techniques that will be employed.  
Lastly, this chapter will describe the statistical methods that will be used to analyze the data.     
Subjects 
 Eight physically active male subjects between the ages of 18-40 years participated in 
this investigation.  In order to be considered physically active, the subjects must have been 
engaged in a minimum of 30 minutes of moderate activity at least four times a week.  
Exclusion criteria for this study included: known infection within three weeks prior to the 
initiation of the study, any major history of medical or orthopedic concerns, any history of 
heat related maladies, being female, claustrophobic tendencies, hydrophobic tendencies, any 
use of anti-inflammatory medications, any history of heart disease, diabetes, or lung disease, 
and a fear of blood draws.   
Instrumentation 
 The subjects’ height was measured using a portable standiometer (Perspectives 
Enterprises, Portage, MI).  Body mass was determined by a mechanical balance beam scale 
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(Detecto, Webb City, MO).  During all exercise trials subjects had their oxygen consumption 
measured by a Parvo Medics TrueMax 2400 metabolic system while cycling on a modified 
mechanically braked cycle ergometer (Monark, Varberg, Sweden).  Subjects were fitted with 
a head set (Hans Rudolph, Wyandottem MI) which held a mouthpiece in place (Vacumed, 
Ventura, CA), allowing for the collection of oxygen consumption data during exercise.  The 
exercise bouts took place in a 1790 liter submersion tank.  During testing core temperature 
(Tre) was monitored by a YSI rectal probe (YSI, Daytona, OH) which was connected to a 
thermistor thermometer (Cole-Palmer, Vernon Hill, Ill).  Skin temperature (Tsk) 
measurements were obtained via YSI skin sensors, which were also connected to a thermistor 
thermometer.  Heart rate (HR) was monitored by a Polar telemetry system (Polar Electro, 
Inc., Finland).  During exercise testing subjects reported rating of perceived exertion (RPE) 
according to Borg’s Original 6-20 RPE scale (Borg 1982).  
 All blood samples were drawn by venipuncture of an antecubital vein using a 3 cubic 
centimeter (cc) Vanishpoint syringe with a 22 gauge, 1” needle (Retractable Technologies, 
Inc. TX).  Blood was then immediately transferred equally into three “3ml” Vacutainer 
tubes (Sterile 13 x 75 millimeters) treated with 5.4 mg of K2 EDTA.  Whole blood samples 
were centrifuged using a Centra 8 refrigerated centrifuge (International Equipment Company, 
Needham Heights, MA).  
Protocol 
The subjects visited the Applied Physiology Laboratory three separate times within a 
two week span.  Each session was separated by at least 48 hours.  The first session consisted 
of the subjects reading and signing the informed consent form, providing their characteristics 
(height, weight and age), filling out a training history form, supplying information for the 
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Department of Exercise and Sport Science Medical History form, undergoing a physical 
examination and performing a graded peak exercise test on a cycle ergometer to determine 
peak oxygen uptake (VO2peak).  During the two experimental trials (sessions two and three), 
which occurred on separate days, subjects performed forty-minutes of submaximal cycling at 
65% of their VO2peak while submerged in water up to the xyphoid process; one session 
occurred with the subjects immersed in 25°C water, while in the other session subjects were 
immersed in 39°C water.  Blood samples were taken immediately prior to exercise, 
immediately post-exercise, and two-hours post-exercise during sessions two and three.  The 
circulating concentration of TNF-α was determined from the blood samples taken during 
each session.   
Session One  
 
 Prior to arriving to the Applied Physiology Laboratory for the first session, subjects 
were contacted via email to alert them to be ready for VO2peak testing.  Within this email a 
detailed description of the exercise test was provided, and subjects were asked to refrain from 
eating for four hours, from consuming caffeine for twelve hours, and from ingesting alcohol 
24 hours prior to the testing.  Subjects were asked to bring the proper attire to the Laboratory 
to allow for underwater testing (athletic shorts and foot apparel of their choice i.e. water, 
kayaking, sandals, running, tennis shoes, or barefoot).  Upon arrival subjects were given the 
opportunity to read the informed consent form, and ask any questions they may have related 
to participation within the study.  After all questions are answered, subjects who were still 
interested in participation signed the consent form.  Subjects then filled out a standard 
Department of Exercise and Sport Science medical history and a training history form.  The 
medical history questionnaire was completed in order to rule out any contraindications to the 
exercise performed in this study.  The training history form was utilized to ensure that the 
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subjects have the minimum training background necessary for participation in the study.  
After providing their age, the subject’s height and body mass was measured.  Following the 
completion of the forms, subjects underwent a physical examination screening.  The physical 
examination was used to identify any contraindications to exercise.     
The subjects were then asked to change into appropriate attire for exercise in the 
water, consisting of athletic shorts, no shirt, and foot apparel of their choice (water or 
kayaking shoes, sandals, running or tennis shoes, or barefoot).  At this time the subjects also 
secured a heart rate monitor around their chests.  Next, the subjects were asked to rest in a 
seated position for ten minutes, with resting oxygen consumption (VO2), heart rate and blood 
pressure measurements being taken at the end of the ten minute period.  Resting VO2 
measurements were taken for three minutes.  After the resting measures were obtained, five 
minutes was allotted for subjects to warm-up on a land based cycle ergometer at a self 
selected workload.  Time was also given to allow the subjects to stretch prior to entering the 
tank.  Following the warm up, subjects secured a weighted belt around their waists to 
overcome buoyancy while immersed and were then guided to a tank filled with 25°C water.  
After entering the tank the water level was adjusted to reach the subjects xyphoid process 
after they were seated on the cycle ergometer.  Subjects were then allowed to get situated on 
the cycle ergometer, while making changes in the seat height and the pedal straps as they saw 
fit (seat height and pedal strap position were recorded to allow for standardization during the 
subsequent trials).  When subjects were comfortable they were fitted with the head set and 
mouthpiece.   
 After becoming comfortable on the cycle the subjects started pedaling and completed 
the graded peak exercise test.  The first stage of the exercise test involved the subjects 
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pedaling at a rate of 40 revolutions per minute (RPM) for a period of five minutes.  At the 
end of the first stage, the pedal rate was increased to 45 rpm and subjects pedaled at the new 
rate for three minutes.  Following the second stage the pedal rate was increased by 5 rpm 
every three minutes until subjects reached volitional fatigue.  VO2, heart rate and rate of 
perceived exertion (RPE) were monitored minute-by-minute throughout the exercise test.  
The test was considered valid if at least two of the following criteria are met: RPE > 18, a 
respiratory exchange ration (RER) >1.10, or a plateau in VO2 with an increase in workload 
(Powers & Howley 2001).  Following termination of the test, the subjects stopped cycling, 
were escorted out of the tank, were dried and began an active recovery consisting of cycling 
at a workload of their choice on a land based cycle ergometer.   Subjects continued the active 
recovery on the cycle ergometer until their heart rate fell below 120 beats per minute (BPM).  
If heart rate failed to fall below 120 bpm in three to five minutes, subjects stopped cycling 
and completed their recovery lying on a cot located within the Applied Physiology 
Laboratory.  Subjects were released from the Applied Physiology Laboratory when their 
heart rates were within 20 beats of the resting rates and blood pressures were within 10 
mmHg of their resting values.  From the graded peak exercise test, a pedal rate equal to 65% 
of the subjects’ VO2peak was computed using the Karvonen method: (0.65 * (VO2peak - 
VO2rest)) + VO2rest (Karvonen et al. 1957).  VO2peak was equal to the maximal oxygen 
consumption achieved during the exercise test, while VO2rest was equal to the mean of the 
values obtained during the last minute of the resting VO2 measurement.   
Experimental Trials  
 
 The two experimental trials followed identical protocols, with the only difference 
being that one session entailed cycling while submerged in 25°C water (cool trial), while the 
other consisted of cycling while submerged in 39°C water (hot trial).  Water temperature was 
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verified immediately prior to and after each exercise bout.  A counter balanced design was 
used to determine the order of exercise water temperature.  Subjects were asked arrive to the 
Applied Physiology Laboratory having refrained from alcohol consumption for 24 hours, 
from caffeine intake for twelve hours and food intake for four hours.  Instructions were given 
indicating that the subjects could drink water any time prior to or after arriving to the 
laboratory.  Subjects were directed to eat their standard pre work out meal prior to arriving to 
the Applied Physiology Laboratory.  The composition and amount of food consumed was 
recorded by the subjects, and a similar meal was consumed prior to the next experimental 
trial. The arrival time of the subjects was held constant for the experimental trials.  For both 
trials, subjects cycled, while submerged in water up to the xyphoid process, for forty-minutes 
at a workload equal to 65% of their VO2peak.   
 The first experimental trial was scheduled at least two days after session one.  Prior to 
beginning the exercise test subjects changed into the same attire, athletic shorts, no shirt, and 
a choice of shoe apparel, used during the peak test performed during session one.  During the 
changing process subjects also self-inserted a rectal thermometer approximately ten 
centimeters into the rectum and strapped a Polar heart rate monitor around their chests.  Skin 
thermisters were then be placed on the subjects’ anterior mid-thigh (Tth), chest (Tch), arm 
(Ta), and head (Th), with surgical tape being used to secure each thermister.  At this point 
subjects were asked to rest quietly in an upright-seated position for twenty minutes.  During 
minutes 10-13 resting VO2 measurements were taken as the subjects are seated.  When the 
nineteenth minute of rest was reached, baseline heart rate, blood pressure, and temperature 
measurements were obtained.  At the end of the twenty minute rest period a 10 milliliter 
(mL) blood sample was drawn via sterile venipuncture of an anticubital vein.  Blood samples 
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were immediately transferred from the syringe into three Vacutainer tubes (Sterile 13 x 75 
millimeters (mm) treated with 5.4 mg of K2 EDTA) and stored on ice during the session. 
 The subjects then secured a weighted belt around their waist and were escorted to the 
tank filled with water which contained the cycle ergometer.  After being immersed up to the 
xyphoid process, baseline temperature and heart rate measurements were recorded with the 
subject seated on the underwater cycle.  After the baseline measurements were made, 
subjects began cycling at a workload estimated to be equal to 65% of their VO2peak.  At 
minute three of the cycling session the subjects’ VO2 data was monitored to ensure they were 
working at 65% of their VO2peak.  If subjects were not working at 65% of their VO2peak, the 
pedal rate was adjusted accordingly.  Following the initial pedal rate adjustments, no more 
changes in pedal rate occurred.  The timing and the magnitude of any changes in pedal rate 
was recorded in order standardize the workloads for the remaining session.  Oxygen 
consumption was sampled via the mouthpiece for the last two minutes of each ten-minute 
interval (minutes 8-10, 18-20, 28-30, 38-40).  Heart rate and RPE was measured and 
recorded during the last minute of each five minute interval.  Core body temperature (Tre) 
and all skin temperatures (Tsk) were monitored during each minute of the exercise session 
and recorded at five minute intervals.  If during the exercise session the subjects’ core body 
temperature rose above 39°C, the subject had an RPE > 19, or if the supervising faculty 
member advised so, the trial was stopped.  If the test was stopped on account of unsafe core 
temperature increases, the subject immediately stopped cycling and was escorted out of the 
tank.  Subjects had access to drinking water at their own discretion during the exercise bout.   
 At the end of the forty-minutes of cycling the subjects were escorted out of the tank 
and were dried.  The subjects were then guided to an upright chair located within the Applied 
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Physiology laboratory where another 9 ml blood sample was obtained via venipuncture of an 
antecubital vein.  Again, the blood sample was be transferred into three K2 EDTA treated 
Vacutainers and stored on ice for later analysis.  Following the second blood sample 
subjects were allowed to perform an active cool down, cycling at a workload of their own 
choice, on a land-based cycle ergometer.  The active recovery continued until the subject felt 
comfortable and water was available at all times during the recovery from exercise.   
 Following the completion of the cool down, subjects changed into a Laboratory 
provided sweat suit and remained in the Applied Physiology Laboratory for two hours.   
Subjects were allowed to move around the Laboratory and participated in activities requiring 
minimal exertion (i.e. reading).  Blood pressure measurements were taken every five minutes 
for the first 20 minutes after the end of exercise to ensure subject safety.  At the end of the 
two hour period, a third 9 ml blood sample was obtained via venipuncture of an antecubital 
vein.  The blood sample were then transferred into three K2 EDTA Vacutainers and stored 
on ice.  After the final blood sample was obtained, final measurements will be taken for heart 
rate, blood pressure, skin temperature and core temperature.  At this point the subjects were 
escorted to a private area within the Applied Physiology where they were allowed to self-
extract the rectal thermometer and change into their regular attire.  If the subject’s heart rate 
had returned to within 20 beats of their resting value, blood pressure had returned to within 
10 mmHg of their resting value, and core temperature had declined to within 1°C of their 
resting value they were released from the Applied Physiology Laboratory.  If the vital 
measurements had not returned to their resting values, subjects were required to remain in the 
Laboratory until the measurements returned to resting values. 
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Biochemical Analysis 
 
Hemoglobin and Hematocrit  
 
Hemoglobin and hematocrit measurements were obtained using the Advia 2120 
hematology system at the Clinical Chemistry Laboratory located within the University of 
North Carolina Memorial Hospital.   
TNF-α Analysis 
TNF-α concentration was determined in duplicate, following the manufacturers 
recommended procedures for an enzyme-linked immunosorbent assay kit (R & D Systems, 
Minneapolis, MN; See Appendix C).  The sensitivity information for the assay used is stated 
in the manufacturers’ assay description.   
Plasma Volume Shifts  
 
 Hematocrit and hemoglobin concentrations were used in order to calculate plasma 
volume shifts (Dill & Costill 1974).  TNF-α concentration was corrected for any shifts in 
plasma volume that may have occurred in order to ensure that any changes observed in 
circulating TNF-α concentration were not due to hemoconcentration.   
Statistical Analysis  
Data analysis was performed using Statistical Package for the Social Sciences (SPSS) 
software, version 15.0 (Chicago, Ill).  The α-level was set a priori at 0.05 for all analyses.  
Descriptive statistics (mean ± standard error) was computed for subjects’ age, height, body 
mass, and VO2peak. Statistical analyses were performed in order to examine the questions 
posed within each research hypothesis. 
Research Hypotheses 
 
1. Exercise in the heat will cause an increase in circulating concentrations of TNF-α 
immediately and two-hours post-exercise when compared to resting levels. 
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a) In order to compare the resting TNF-α concentration and the concentration 
measured immediately and two hours post-exercise a one way repeated measures 
analysis of variance (ANOVA) was used.  If the ANOVA produced significant 
results, a Tukey post hoc analysis was performed to detect at which time points 
during exercise and recovery the TNF-α concentration was significantly different 
then resting values. 
2. Exercise in the heat will elicit greater changes in circulating TNF-α concentration 
immediately and two-hours post-exercise when compared to exercise in a cool 
environment.  
a) In order to compare the TNF-α response to exercise in a warm environment and 
exercise in a cool environment, changes (∆ values) in TNF-α concentration were 
calculated for pre-post and pre-two hours post exercise measurements.  A 2x2 
totally-within subjects ANOVA was then used to compare the changes in TNF-α 
concentration that occurred during each trial.  If a significant difference was 
found, a Tukey post hoc analysis was used to determine at which time points 
during the experimental trials the differences in TNF-α concentration occurred.    
3.  A significant positive relationship will exist between changes in TNF-α concentration and 
the changes in core temperature. 
a) A Pearson Product Moment Correlation was used to examine the relationship 
between changes in circulating TNF-α concentration and changes in core 
temperature. 
  
 
 
 
Chapter IV 
 
Results 
 
Subjects 
 
 Eight healthy men served as subjects.  At the time of participation all subjects were 
engaging in a minimum of 30 minutes of moderate physical activity at least four times a 
week.  The subjects were 24 ± 1.7 (mean ± SD) years of age, 1.80 ± 0.06 m in height, 78.3 ± 
6.06 kg in body mass, and had an average body mass index (BMI) of 24.2 ± 1.9 kg/m2.  
Subjects had a VO2peak of 52.8 ± 3.7 ml/kg/min or 4.1 ± 0.4 L/min.  One subject did not 
meet the previously established criteria set to produce a valid VO2peak, as the VO2peak 
testing was stopped due to an inability to maintain pedal cadence.  Statistical analysis of the 
VO2 data involved the results of all eight subjects.     
Exercise Trials 
 Subjects completed two underwater cycling exercise trials, one in a cool temperature 
of 25.5 ± 0.02°C and the other trial in a hot temperature of 38.1 ± 0.06°C. These two exercise 
trials will be referred to as cool and hot throughout this document.  Three of the eight 
subjects were not able to complete the full forty minutes of exercise in the hot environment.  
Two subjects stopped the exercise trial due to volitional fatigue, at minutes thirty and thirty 
five, respectively, and a third subject was stopped at minute thirty due to safety concerns 
involving increases in core temperature.  Data from all eight subjects was used during 
statistical analysis.  For the subjects who did not complete the full forty minutes of exercise, 
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the last measurement taken immediately prior to the end of exercise was used as the final 
measurement.  
Table 3 shows the VO2 (ml/kg/min) values for each exercise trial.  For both trials, the 
average VO2 (ml/kg/min) was not significantly different (p > 0.05) from the prescribed 
workload of 65% of VO2peak.  No significant difference (p > 0.05) was observed between 
the average VO2 (ml/kg/min) values when the two trials were compared. At all time points 
during exercise, heart rates were found to be significantly higher (p < 0.05) during exercise in 
the heat when compared to exercise in the cool environment.  Rate of perceived exertion 
(RPE) values were significant higher (p < 0.05) at minutes 20, 30 and immediately prior to 
the end of exercise in the hot trial when compared the cool trial.   
 
Table 3. Mean (± SD) Heart rate (HR), rate of perceived exertion (RPE) and oxygen uptake 
(VO2) responses to moderate intensity exercise in a cool (25°C) and hot (39°C) environment.  
* (p < 0.05, Hot vs. Cool) 
 
  
Core temperatures measurements were recorded at rest, minutes 10, 20, 30 and 
immediately prior to the end of the exercise bouts (Figure 1).  Core temperature was found to 
HR (bpm) RPE VO2 (ml/kg/min) Time 
(min) Cool Hot Cool Hot Cool Hot 
Rest 66 ± 5 66 ± 5 -- -- 4.4 ± 1.2 4.2 ± 0.6 
10 135 ± 22 166 ± 26 * 13 ± 2.0 14 ± 2.7 31.4 ± 3.7 33.0 ± 4.4 
20 141 ± 21 177 ± 20 * 13 ± 2.3 15 ± 2.5 * 33.3 ± 2.9 35.5 ± 2.7 
30 143 ± 19 181 ± 18 * 14 ± 2.0 16 ± 2.5* 33.6 ± 4.0 34.5 ± 4.1 
Final  144 ± 8 180 ± 12 * 14 ± 1.9 16 ± 2.1* 34.3 ± 3.6 35.6 ± 5.8 
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be significantly higher (p < 0.05) at minutes 20, 30 and at the end of exercise in the hot trial 
when compared to the cool trial.   
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Figure 1: Mean (± SD) Core temperature responses to moderate intensity exercise in a cool 
(25°C) and hot (39°C) environment.  * (p < 0.05, Hot vs. Cool)       
 
 
Hematocrit and hemoglobin measurement were made on all pre-, post-, and two hours 
post-exercise blood samples to calculate plasma volume shifts during the exercise and the 
two hours of rest post exercise.  For the cool exercise trial, the average plasma volume loss 
during exercise was -4.8 ± 4.4%, and the average loss pre-exercise to two hours post exercise 
was -2.3 ± 3.8%.  In the hot exercise trial, the average plasma volume loss during exercise 
was -8.8 ± 5.3%, and the average loss pre-exercise to two hours post exercise was -1.8 ± 
3.7%.  All TNF-α measurements were corrected for plasma volume changes prior to 
statistical analysis.   
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TNF-α Responses 
 Plasma TNF-α concentration was determined from blood samples taken immediately 
prior to, immediately post and two hours after each exercise bout.  The plasma TNF-α 
concentration for all samples is illustrated in Figure 2.  No significant effect of time (p > 
0.05) on the circulating TNF-α concentration was evident during either the hot or cool trials.  
The results of a 2x3 within subjects ANOVA revealed no significant difference (p > 0.05) in 
TNF-α concentration at rest, immediately post or two hours post-exercise when the hot and 
cool trials were compared.   
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Figure 2: Mean (± SD) Plasma TNF-α concentrations observed in response to moderate 
intensity exercise in a cool (25°C) and hot (39°C) environment.   
 
Changes (∆) in TNF-α concentration were calculated by subtracting the pre-exercise 
concentration from the post-exercise concentration and subtracting the pre-exercise 
 44 
concentration from the two hour post-exercise concentration.  The change values are 
illustrated in Figure 3.  The results of a 2x2 within subjects ANOVA revealed no statistically 
significant differences (p > 0.05) between changes in TNF-α concentration in response to 
exercise in the cool environment when compared to the changes induced by exercise in the 
heat.   
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Figure 3: Mean (± SD) Changes in TNF-α concentration in response to exercise in a cool 
(25°C) and hot (39°C) environment.   
 
Correlation Analysis   
 A correlation coefficient (Pearson) was calculated between the change in TNF-α 
concentration and the exercise-induced change in core temperature.  The correlation 
coefficient, r = 0.366, was not statistically significant (p > 0.05).  A correlation coefficient 
 45 
was also calculated between the change in TNF-α concentration and the exercise-induced 
change in heart rate values and it was also not statistical significant ( r = 0.209; p > 0.05).   
    
 
 
    
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter V 
 
Discussion 
 
 
 The purpose of the present study was to determine whether exercising in a warm 
environment affects the magnitude of change in circulating TNF-α concentration.  Eight male 
subjects performed two moderate-intensity cycling exercise sessions; one immersed in a 
water temperature of 39°C and the other in 25°C water.  Plasma TNF-α concentration was 
determined from blood samples taken immediately prior, immediately post and two hours 
after each forty-minute exercise session.   
Exercise Trials  
 Core temperature was significantly higher (p < 0.05) during the hot trial when 
compared to the thermoneutral trial.  During each of the trials subjects were submersed in 
water up to the mid-chest level, which is equal to approximately 65% of the total surface of 
the body being underwater (Hardy & DuBois 1938).  Convective heat gain would be greater 
in the hot trial because the 39°C temperature of the water is well above average core body 
temperature, while the 25°C temperature of cool trial is below average core body temperature 
(Powers & Howley 2001).   The increased convective heat gain, coupled with an increase in 
metabolic heat production due to exercise, caused a very rapid increase in core temperature 
during the hot trial.  It may be of interest to note that large increases in core temperature 
(2.28 ± 0.40°C) can be induced very quickly via an acute bout of moderate-intensity exercise 
and partial submersion of the body in 39° C water.           
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Significant differences (p < 0.05) were noted in the heart rates between the two trials, 
as higher rates were seen in the hot trial when compared to the cool trial.  Since the two trials 
had similar VO2 values, the increased heart rates observed during the hot trial were not due to 
an increased workload, but were due to the increased heat stress that was placed on the body 
(Powers & Howley 2001).  Stroke volume is compromised during exercise in the heat due to 
a decrease in blood flow back to the heart, which stems from a need to divert more blood 
flow to the periphery in order to dissipate heat (Powers & Howley 2001).  As previous 
research suggests, heart rate would have to be increased in the hot trial in order to maintain 
cardiac output in response to the decreased stroke volume (Powers & Howley 2001).   
RPE was also significantly higher (p < 0.05) during the hot trial when compared to 
the cool trial.  This finding is similar to those observed within previous research published by 
Nybo and Nielsen (2001), in which elevated RPE values were reported in response to a 40°C 
exercise trial when compared to an 18°C trial.  Additional findings from the Nybo and 
Nielsen (2001) study suggest that during exercise in the heat perceived exertion is associated 
with increases in core temperature and central fatigue, but not muscular fatigue (Nybo & 
Nielsen 2001).  This may imply that the increased RPE observed during the hot trial of the 
present study was not an indicator of an increased muscular workload, but rather a gauge of 
the stress being placed on the central nervous system by the hot environment. 
TNF-α Responses 
 The resting TNF-α concentrations observed in the present study were similar for all 
testing sessions and are comparable to those measured in similar studies (Peake et al. 2007, 
Starkie et al. 2005).  Resting measures of hematocrit and hemoglobin were also within a 
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normal range, indicating that the subjects possessed normal physiological fluid 
characteristics (Tietz 1990).   
 No significant changes (p > 0.05) were detected in plasma TNF-α concentration 
immediately-post or two-hours post-exercise following exercise in a cool environment.  This 
finding is supported by previous research (Febbraio et al. 2003, Smith et al. 1992, Ullum et 
al. 1994).  Febbraio et al. (2003) examined the effect of cycling at an intensity of 60% of 
VO2peak for 25 minutes and observed no significant change in TNF-α concentration post 
exercise.  Smith et al. (1992) also reported no significant change in circulating TNF-α 
concentration following an acute exercise bout consisting of sixty minutes of exercise at 60% 
of VO2max.  Similar results were observed by Ullum et al. (1994), which found no 
significant increase in TNF-α concentration in response to sixty minutes of cycling at 75% of 
VO2max.  The results of the present study, as well as other studies, suggest that acute 
exercise in a cool environment has no affect on circulating TNF-α concentration.   
No significant changes (p > 0.05) in TNF-α concentration were observed 
immediately-post or two hours post-exercise following exercise in the heat. This finding is 
not supported by the studies published by Rhind et al. (2004), Starkie et al. (2005), and Peake 
et al. (2007).  In a study by Rhind et al. (2004), that used a similar exercise protocol as the 
present study, significant increases in TNF-α concentration were reported immediately 
following exercise.  Starkie et al. (2005) measured circulating TNF-α concentration 
following ninety minutes of cycling at 70% of VO2peak in an air temperature of 35°C and 
reported elevated TNF-α levels immediately following exercise. Significant increases in 
TNF-α concentration immediately after exercise were also observed in a study published by 
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Peake et al. (2007), in which subjects cycled for ninety minutes at 60% of VO2max in an air 
temperature of 32°C.   
 One possible factor that may have contributed to the conflicting results of the present 
study and previously published research could be the duration of the exercise sessions.  
Rhind et al. (2004) suggests that the extent of cytokine changes during exercise is related to 
the magnitude of the stress that is placed on the body, which is directly influenced by the 
duration of the exercise bout.  Two of the three studies reporting increases in circulating 
TNF-α concentration immediately following exercise, involved at least ninety minutes of 
exercise (Starkie et al. 2005, Peake et al. 2007).    In may be the case that the forty minutes of 
exercise performed in the present study did not place sufficient stress on the body and 
therefore did not induce significant changes in the circulating TNF-α concentration.  The 
effect of exercise duration on TNF-α concentration may be a point that future research needs 
to address. 
 Training status may influence the TNF-α response to acute exercise (Moldoveanu et 
al. 2001), such that highly active, endurance trained individuals have lower TNF-α responses 
during moderate exercise.  In contrast to this finding, the study published by Rhind et al. 
(2004) reported significant elevations of TNF-α in all subjects (n = 8) in response to acute 
exercise in the heat, but utilized a subject pool with a wide range of VO2peak values (39.3 to 
75.4 ml/kg/min).  The physical activity levels of the subjects were not reported.  The results 
of the present study would disagree with the Rhind et al. findings.  The lack of physical 
activity data presented may play a role in the differing findings, as aerobic power (VO2peak) 
may not be representative of the training status of the subjects.   Since aerobic power can be 
influenced by multiple factors, i.e. genetics, it may not necessarily indicate the actual training 
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status of the subjects.  The subjects used for the present study were active at least for times a 
weak, and may have been more homogeneous in their training status than the subjects of the 
Rhind et al. study.  If the subjects in the present study were more endurance trained, it may 
have resulted in a different TNF-α response to exercise in the heat when compared to the 
Rhind et al. study.   
 A third factor that may have played a role in the conflicting results is the mode of 
exercise that was used within the present study.  Two of the three studies that found 
significant increases in TNF-α concentration following exercise in the heat used a land based 
cycling protocol (Starkie et al. 2005, Peake et al. 2007), while the present study used a water 
based protocol.  A previously published study investigating muscle activity in land based 
exercise compared to submerged exercise reported less muscle activity and lower percentage 
of maximal voluntary contraction during the submerged activity (Kaneda et al. 2007).  If 
submerged exercise requires lower levels of muscular activity, it may not induce the same 
amount of muscular damage as a similar amount of land based exercise would.  Since 
increased cellular debris release from injured muscles is one of major mechanisms that can 
lead to increased TNF-α concentrations, it would follow that lower muscular damage would 
lead to a reduced TNF-α response.  In this way the submerged exercise used in the present 
study may have led to a decreased TNF-α response when compared to the studies that 
utilized land based cycling protocols.   
 The small sample sizes used in the studies could have also influenced the divergent 
results.  Of the three studies that reported a significant increase in TNF-α post exercise, the 
largest subject pool was seen in the Peake et al. (2007) study, which had ten male 
participants.  As the two other studies with significant results, and the present study, had 
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subject pools less than ten, individual variability in the TNF-α response to exercise could 
have largely influenced the differing results.    
Limitations 
 Although the sample size of eight subjects used is comparable to the sizes used in 
previously published investigations, it still very small and may have limited the present study 
(Rhind et al. 2004, Starkie et al. 2005, and Peake et al. 2007).  A second limitation stems 
from three of eight subjects failing to complete exercise during the warm trial.  Further 
inspection of their individual results shows that even though they did not finish the hot trial, 
their responses were similar to subjects who completed the full trial.     
Summary 
 The present study was designed to examine the change in circulating TNF-α 
concentration in response to a forty minute moderate-intensity exercise session in a warm 
environment.  Eight male subjects performed two cycling sessions at 65% VO2peak; one 
while immersed in a water temperature of 39°C and the other in 25°C water.  Plasma TNF-α 
concentration was determined from blood samples taken immediately prior to, immediately 
post and two hours after each exercise session.  Neither of the two experimental trials elicited 
a significant increase in TNF-α concentration over resting values immediately post or two 
hours post-exercise.  No significant differences were revealed in TNF-α concentration at rest, 
immediately post or two-hours post-exercise when the two trials were compared.   
Conclusion 
 The results of the present study indicate that for moderately trained men, forty 
minutes of moderate-intensity exercise in a cool or hot environment does not elevate TNF-α 
concentration immediately post or two hours post-exercise.  Therefore, research hypothesis 
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one, exercise in a warm environment will cause an increase in circulating concentrations of 
TNF-α immediately and two hours post-exercise when compared to resting levels, was 
rejected.  No difference in circulating TNF-α concentration was observed between the cool 
and hot trials immediately post or two hours post-exercise.  As a result of this finding, 
research hypothesis two, exercise in a warm environment will elicit greater changes in 
circulating TNF-α concentration immediately and two hours post-exercise when compared to 
exercise in a cool environment, was also rejected.  Additionally, no relationship was 
observed between change in core temperature and change in TNF-α concentration, which led 
to rejection of hypothesis three, which stated that a significant positive relationship will exist 
between changes in TNF-α concentration and the changes in core temperature. 
Recommendations 
 Based upon the results of the present study, further research examining additional 
exercise durations is recommended to provide a clearer outline of the effect of exercise in the 
heat on the TNF-α response to exercise.  The effect of training status on the TNF-α response 
is another area that warrants further investigation.  Lastly, it is recommended that future 
studies involve the use of larger sample sizes in order to increase the power of statistical 
analyses and enhance external validity.   
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University of North Carolina-Chapel Hill 
Consent to Participate in a Research Study  
Adult Subjects age 18-40 
Biomedical Form 
 
IRB Study # 07-1827  
Consent Form Version Date: 12.5.2007  
 
Title of Study: The Effect of Exercise in a Warm Environment on Tumor Necrosis Factor-α 
Concentration and Circulating Neutrophil Count 
 
Principal Investigator: Mark Berry and Erica Cooper  
UNC-Chapel Hill Department: Exercise and Sport Science  
UNC-Chapel Hill Phone number: (919) 609-8915, (757) 642-3670 
Email Address: bgmark@email.unc.edu, escooper@email.unc.edu  
Co-Investigators:  
Faculty Advisor: Robert G. McMurray, Ph.D.  
Funding Source: University of North Carolina-Chapel Hill Exercise and Sport Science 
Department 
 
Study Contact telephone number:  (919)-609-8915, (757) 642-3670 
Study Contact email:  bgmark@email.unc.edu, escooper@email.unc.edu  
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  You 
may refuse to join, or you may withdraw your consent to be in the study, for any reason. 
 
Research studies are designed to obtain new knowledge that may help other people in the 
future.  You may not receive any direct benefit from being in the research study. There also 
may be risks to being in research studies. 
 
Deciding not to be in the study or leaving the study before it is done will not affect your 
relationship with the researcher, your health care provider, or the University of North 
Carolina-Chapel Hill.  If you are a patient with an illness, you do not have to be in the 
research study in order to receive health care.  
 
Details about this study are discussed below.  It is important that you understand this 
information so that you can make an informed choice about being in this research study.  
You will be given a copy of this consent form.  You should ask the researchers named above, 
or staff members who may assist them, any questions you have about this study at any time. 
                                    
What is the purpose of this study?  
Background:  Stress, either physical or mental, has been shown to alter immune function.  
Two stressors that are known to alter immune function individually include exercise and heat 
exposure.  While many studies have examined the effects of heat and exercise individually 
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on immune function, little research has been devoted to exploring the combined effect of 
exercise and heat on immune function.  Any disruption of immune function due to exercise in 
the heat may be of particular importance to coaches, athletes, physicians, and individuals 
whose professions require activity in warm environments (firefighters, military personnel).  
The current study will focus on the effect of exercise in the heat on two markers of immune 
function:  Tumor Necrosis Factor-α (TNF-α) and Neutrophils. 
 
The purpose of this research study is two fold; 1) to determine how exercise in the heat 
effects the TNF-α concentration in the blood and 2) to determine how exercise in the heat 
effects the number of circulating neutrophils in the blood. 
 
You are being asked to be in the study because you are a recreationally active male between 
the ages of 18 and 40 who does not have a history of heart disease, a history of infection 
within the past three weeks, an injury hindering your ability to exercise, claustrophobic 
tendencies, or a fear of blood draws or water. 
 
Are there any reasons you should not be in this study? 
You should not be in this study if you are female, have a history of heat related problems, 
heart disease, diabetes or diseases affecting your lungs (such as asthma), are not between the 
ages of 18-40, have an orthopedic injury that would hinder your ability to exercise, are not 
comfortable with water, have claustrophobic tendencies, if you are currently on anti-
inflammatory medications, or if you are not comfortable with blood draws.  Also, you should 
not be in this study if you have had an infection within the past three weeks.   
 
How many people will take part in this study? 
If you decide to be in this study, you will be one of approximately eight people in this 
research study. 
 
How long will your part in this study last?  
Your participation in the study will consist of three sessions.  The first session will take 
approximately 1.5 hours.  The second and third sessions will take approximately 3.5 hours.  
The first session will be used to conduct a physical exam, to determine your peak aerobic 
capacity, and to establish the exercise intensity for the following two sessions.  The two 
exercise sessions will involve sub-maximal exercise.  They will be separated by at least 24 
hours, and must occur within 2 weeks of the first test session.     
 
What will happen if you take part in the study? 
You will be asked to complete three exercise sessions.  Each session will consist of 
approximately 40 minutes of actual exercise.  The first session will be used to obtain your 
consent, weight and height measurements, to complete a physical exam, and to complete a 
peak exercise test.    
 
You will arrive to the Applied Physiology Laboratory for the first appointment having 
refrained from alcohol consumption for the past 24 hours.  Immediately after arriving to the 
lab you will read and sign the informed consent form.  Once you have agreed to participate 
and sign the consent form, you will fill out a medical history form and have your weight and 
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height measured.  You may elect not to answer any of the questions on the medical history 
form; however, this may result in your exclusion from the study.  You will complete the 
standard Applied Physiology Laboratory medical screening history and undergo a physical 
examination administered by Dr. McMurray.   
 
Next, you will be given the opportunity to practice cycling on a stationary bike, while also 
taking time to stretch and warm up before the exercise test. You will then strap a battery 
operated heart rate monitor around your chest.  Before beginning the test, you will practice 
breathing through a mouthpiece apparatus.  When comfortable, you will move to a different 
cycle ergometer that is immersed into chest high water of a cool temperature (25° Celsius, 
77° Fahrenheit).  You will climb down large no-slip stairs into the tank with assistance.  
Before entering the tank, you will change into appropriate underwater attire: your own 
athletic/swimming trunks and no shirt.  You may wear shoes (water, kayaking, sandals, 
running or tennis shoes) or perform the underwater cycling barefoot.  Your clothing and shoe 
choice must remain consistent throughout all 3 exercise trials.  You will then sit on the cycle 
ergometer for two minutes while your oxygen consumption is measured.  After two minutes, 
the graded peak cycling test will begin.  The first stage of the test will last 5 minutes, and you 
will cycle at 40 rpm.  At the end of the five-minute stage, the pedal rate will increase to 50 
rpm.  You will cycle at the new pedal rate for three minutes.  From then on, you will increase 
your pedal rate by 5 rpm every three minutes until you are too tired to continue. At this point, 
the exercise test will be stopped.  You will recover by cycling at a very low pedal rate until 
your heart rate drops below 120 beats per minute.  If your heart rate does not drop below 120 
beats per minute within 3-5 minutes, you will stop cycling, be escorted out of the tank, dried 
off, and continue recovery lying down on a cot until your heart rate does decline below 120 
beats per minute.  Once your heat rate has slowed to within 20 beats of your resting rate, and 
blood pressure has returned to within 10 mmHg of your resting pressure, the next exercise 
trial will be scheduled, and you will be released.  If you become uncomfortable at any point, 
you may stop the test.  The test may also be stopped if the situation becomes unsafe or if any 
member of the research team decides to stop the test.   
 
The procedures for the experimental trial and the control trial are the same, except for the 
water temperature in which you will be immersed.  In the control trial, you will cycle while 
immersed in cool water (25° Celsius; 77° Fahrenheit) and in the experimental trial, you will 
cycle while immersed in warm water (39° Celsius; 102° Fahrenheit).  The temperature of 
water for the warm trial is lower than the temperature of most hot tubs.  Water temperature 
for the exercise sessions will be randomly assigned.  For 24 hours leading up the trials, you 
must abstain from exercise and alcohol consumption.  Approximately 4 hours prior to 
arriving at the Applied Physiology Laboratory, you will eat a meal typical to what you might 
eat prior to a regular workout.  After this meal you will not be allowed to consume any food 
until the end of the trial.  Please avoid alcohol for 24 hours and caffeinated drinks for a 
minimum of 4 hours before the exercise trials. During the trial, you will be allowed to drink 
water at your discretion.   
 
After arriving at the Applied Physiology Laboratory for exercise trials 2 and 3, you will 
change into appropriate attire (athletic/swimming shorts and no shirt) and self-insert a battery 
operated rectal thermometer.  The rectal thermometer consists of a small circular electric 
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temperature sensor (approximately the size of a small button) connected to a wire.  The other 
end of the wire will be connected to a thermister thermometer, allowing the core temperature 
readout to be seen.  The rectal thermometer will allow for the accurate and continuous 
monitoring of internal temperature changes during exercise and will ensure your safety 
during the exercise sessions.  Battery powered skin thermisters will be attached to your mid-
thigh and chest to monitor changes in skin temperature.  Then, you will rest quietly, sitting in 
an upright position for twenty minutes.  At minute 19 of the rest period, your heart rate and 
blood pressure will be measured.  At the end of the 20 minutes of rest, a trained individual 
will use a sterile technique to draw a 10 ml (~2 teaspoons) blood sample.  Your blood sample 
will be labeled with your subject identification number, and stored for analysis.   
 
 After the first blood draw, you will enter the water tank.  You will be immersed in 
water to the mid-chest level during exercise.  When you are fully submerged, you will begin 
a 5-minute warm-up period, cycling at a self-selected pace.  During this time, a member of 
the research team will ensure that you are comfortable with the cycle ergometer, headset and 
mouthpiece apparatus used to measure oxygen consumption, and water submersion. 
 
After the warm-up, you will begin the exercise test. You will cycle for 40 minutes at 65% of 
your peak exercise capacity, while submersed up to the mid-chest in water.  After four-
minutes of exercise, your expired air will be monitored for one minute to ensure that you are 
exercising at the 65% of your peak capacity.  If you are not exercising at the correct intensity, 
pedal rate will be adjusted as needed.  Pedal rates in the second session will be exactly the 
same as the first session.  Your expired air will be sampled for the last 4 minutes of each ten-
minute interval (minutes 6-10, 16-20, 26-30, 36-40).  Throughout the 40 minutes of exercise, 
your heart rate and rating of perceived exertion will be recorded during the last 15 seconds of 
each five-minute interval.  Also, your internal temperature (via rectal thermometer) and skin 
temperature (via skin thermisters) will be monitored every minute and recorded at five-
minute intervals to ensure your safety.  During the exercise test, you will have access to 
water at any point.  Again, if you become uncomfortable at any point, or if the research team 
deems in necessary, the test may be stopped.   
 
After 40 minutes, you will stop cycling and your headset and mouthpiece apparatus will be 
removed.  You will be assisted walking up the stairs and out of the water tank, and dried off.  
A research assistant will escort you to an upright chair where again, a trained individual will 
use a sterilized procedure to obtain another 10 ml (~2 teaspoons) blood sample.    You will 
then move to a stationary bicycle located in room air to cool down at a self-selected pace 
until you are comfortable.  Again, you may drink water at any time.   
 
After the cool down period, you will put on a sweat suit (provided by the Applied Physiology 
Laboratory) to keep warm. You will remain in the laboratory for two hours, during which 
you may walk around the laboratory, use the bathroom, read or study.  Magazines will be 
made available for you to read during this time.  After two hours, a trained individual will 
take a third 10 ml (~2 teaspoons) blood sample using a sterile procedure.  The location of 
puncture will be cleaned and bandaged.  You will schedule the next experimental trial and 
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ask any questions you may have.  You will be allowed to leave the Applied Physiology 
Laboratory when your heart rate is within 20 beats/minute of your resting rate, your blood 
pressure is within 10 mmHg of your resting blood pressure, and your core temperature drops 
below 38° C (100° F).          
 
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge.  Upon completion of this 
study, athletes, coaches, physicians, and individuals engaged in activity in heat will have a 
greater understanding of the immune system’s response to activity in the heat, specifically, 
how exercise in the heat may or may not increase the risk of illness.  You will also have the 
benefit of knowing your sub-maximal and peak aerobic capacity and heart rates, which may 
be valuable for your training; however, you may not benefit directly from participating in this 
study.   
 
What are the possible risks or discomforts involved with being in this study?  
There should be no risk of psychological harm from completing the research; therefore there 
should be no emotional distress.   
 
You will be asked to complete very strenuous exercise bouts during participation within this 
study.  When completing strenuous exercise some common side effects may include, muscle 
soreness, fatigue.  As you are accustomed to regular exercise the muscle soreness and fatigue 
should be minimal.  Uncommonly, strenuous exercise has also been associated with the risk 
of heart attack or stroke, as there is a 1 in 10,000 chance that a healthy subject may 
experience an adverse event during aerobic fitness testing.  However, the following 
precautions are in place to minimize the risk including: close supervision, pulse rate 
monitoring, periodic blood pressure monitoring, pre-physical examinations and extensive 
medical screening.  The supervising faculty (Dr. McMurray) and the exercise research test 
assistants are trained in exercise stress testing, cardio-pulmonary resuscitation, and the use of 
an automated defibrillator device.  Dr. McMurray, PhD., has maintained his certification with 
the American College of Sports Medicine (originally certified in 1982), which ensures 
current knowledge/expertise in exercise testing special populations, including older adults 
and those with disease processes.  Supplemental oxygen is available in the lab along with a 
telephone with posted emergency call instructions for notifying campus security to arrange 
medical transport for the subject to UNC hospital.  Further, a fully equipped Sports Medicine 
Rehabilitation facility is located 100 yards away.           
 
You will also be asked to provide blood samples during the experimental trials.  The blood 
draws will be conducted by a trained individual, Dr. McMurray, from the University of North 
Carolina-Chapel Hill Applied Physiology Laboratory.  All standard safety and sterile 
procedures will be used during all blood draws.  If minor bruising does develop as a result of 
the blood draws, ice and compression will be applied to the area.  Also, the total amount of 
blood drawn (approximately 30 ml) is small and should have no adverse effects. 
   
Upon entering and exiting the water tank, there is a small risk of slipping or falling.  The 
water tank in which the cycle will be immersed is equipped with large no-slip steps that 
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provide easy access for you.  You will also be provided assistance to aid your balance as you 
enter and exit the tank.  Absorbent towels will cover the floor area surrounding the water 
tank to prevent accidental slips or falls.  Additionally, the tank provides easy access in the 
event that the investigators need access to you during your exercise sessions.  Although the 
water comes up only to your chest, there is a small risk of accidental submersion.  In order to 
minimize this risk, a flotation device will be available while you are in the water.  Also, once 
the cycle ergometer is in place in the tank, there is little space for you to move around the 
tank, reducing the potential for submersion  
 
There is the minor risk of developing a degree of temperature related stress, including heat 
cramps, heat exhaustion, or heat stroke.  Constant monitoring of core temperature via a 
battery operated rectal thermometer, which is the most reliable method of monitoring core 
temperature, minimizes this risk.  Additionally, studies involving exercise combined with 
heat exposure have been performed in UNC Chapel Hill’s Applied Physiology Laboratory 
since the mid-1980s with no adverse effects reported.  You will be carefully monitored 
during all exercise sessions, and testing will stop if core temperature exceeds 39° C (102° F).   
 
In the case that your core temperature does rise above 39°C (102°F) during exercise, 
immediate action will be taken in order to cool you off.  You will be escorted out of the tank, 
dried off, and guided to a separate area of the Applied Physiology Laboratory.  Once 
completely dry, all uncovered areas of your skin will be sprayed with cool water, while a fan 
blows air across your body.  Evaporative cooling will be increased and your internal body 
temperature will begin to go down.  This method of cooling is regularly used to treat heat 
related illnesses and has been shown to cause rapid drops in internal body temperatures.  
Another member of the team will also apply ice to your neck in order to augment the cooling 
process.  The entire cooling protocol will continue until your internal temperature drops to 
within one degree of your resting temperature.  Monitoring your body temperature during 
exercise and use of these cooling protocols in case your internal temperature exceeds 39°C 
(102°F) will help to avoid any large increases in internal temperature.     
 
Although the use of rectal thermometry is considered a safe method of internal temperature 
measurement, it has been associated with a small increase in the risk of infection.  In order to 
combat this risk all thermometers will be stored within disinfected area of the laboratory, and 
will be cleaned with an alcohol solution following every use.  Taking these steps to sterilize 
the thermometers should negate any increased risk of infection. 
 
If you fall, strain a muscle, or in any way injure yourself during the exercise testing process, 
first aid will be provided.  
 
Although no radioactive materials are being used for this study, the UNC Chapel Hill 
Applied Physiology Laboratory, where you will be performing exercise tests, houses 
radioactive materials.  The amount of radioactive material is very small and should pose no 
health threat to you.  All radioactive material is stored in a contained biochemistry section of 
the Applied Physiology Laboratory, and is kept in compliance with the UNC Office of 
Environmental, Health & Safety regulations.   
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In addition, there may be uncommon or previously unknown risks that might occur.  You 
should report any problems to the researchers. 
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might 
affect your willingness to continue your participation.   
 
How will your privacy be protected?   
No subjects will be identified in any report or publication about this study. Although every 
effort will be made to keep research records private, there may be times when federal or state 
law requires the disclosure of such records, including personal information.  This is very 
unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by law 
to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University, research sponsors, or 
government agencies for purposes such as quality control or safety.    
 
Upon agreement to participate in the study, each participant will be assigned an ID number.  
All data will be stored by ID number in a computer that is password protected.  Only the 
researchers and the faculty adviser will have access to this information.  Once you have 
completed all three trials, your name, telephone number, and email address will be destroyed. 
The data will be kept by ID with no other identifiers.  All data collection sheets and 
questionnaires used for data collection will be kept in a locked filing cabinet located in room 
25B Fetzer Gym (Dr. McMurray’s office).  After every trial, a research team member will 
transfer all data to the computer.   
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include 
the risk of personal injury. In spite of all safety measures, you might develop a reaction or 
injury from being in this study. If such problems occur, the researchers will help you get 
medical care, but any costs for the medical care will be billed to you and/or your insurance 
company. The University of North Carolina at Chapel Hill has not set aside funds to pay you 
for any such reactions or injuries, or for the related medical care.  However, by signing this 
form, you do not give up any of your legal rights. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have 
the right to stop your participation at any time. This could be because you have had an 
unexpected reaction, or have failed to follow instructions, or because the entire study has 
been stopped. 
 
Will you receive anything for being in this study? 
You will be allowed to retain a copy of your personal test data to aid you in planning your 
training.  Otherwise, you will not be compensated for participation in this study. 
  
Will it cost you anything to be in this study? 
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It will not cost you anything to take part in this study.  If you enroll in this study, you will 
have to pay for your own transportation.  Parking behind Fetzer Gym will be provided for 
those coming from off campus. 
 
What if you are a UNC student? 
You may choose not to be in the study or to stop being in the study before it is over at any 
time.  This will not affect your class standing or grades at UNC-Chapel Hill.  You will not be 
offered or receive any special consideration if you take part in this research. 
 
What if you are a UNC employee? 
Taking part in this research is not a part of your University duties, and refusing will not affect 
your job.  You will not be offered or receive any special job-related consideration if you take 
part in this research.   
 
Who is sponsoring this study? 
There is no outside funding for this study, as the study will be sponsored by the University of 
North Carolina - Chapel Hill Applied Physiology Laboratory. The researchers do not have a 
direct financial interest in the final results of the study  
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions, or if a research-related injury occurs, you should contact the 
researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research subject? 
All research on human volunteers is reviewed by a committee that works to protect your 
rights and welfare.  If you have questions or concerns about your rights as a research subject 
you may contact, anonymously if you wish, the Institutional Review Board at 919-966-3113 
or by email to IRB_subjects@unc.edu. 
 
Title of Study:  The Effect of Exercise in a Warm Environment on Tumor Necrosis 
Factor-α Concentration and Circulating Neutrophil Count 
 
Principal Investigators:  Mark P. Berry and Erica S. Cooper 
 
Subject’s Agreement:  
 
I have read the information provided above.  I have asked all the questions I have at this time.  
I voluntarily agree to participate in this research study. 
 
_________________________________________   _________________ 
Signature of Research Subject     Date 
 
_________________________________________ 
Printed Name of Research Subject 
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_________________________________________  _________________ 
Signature of Person Obtaining Consent   Date 
 
_________________________________________ 
Printed Name of Person Obtaining Consent  
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Appendix B 
 
Training History, Medical History and Physical Exam Forms  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright held by the University of North Carolina At Chapel Hill 
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Department of Exercise and Sport Science  
Training History Form 
 
 
Are you currently involved a regular exercise program?   ____ yes ____ no 
 
Do you regularly walk or run one or more miles continuously?  ____ yes ____ no 
How often per week? ____________ 
 
Do you participate in other forms of regular aerobic exercise?  ____ yes ____ no 
If yes, average number of miles covered per workout or day:  ____miles____? 
 
Do you regularly lift weights?      ____ yes ____ no 
______# times/wk 
 
Do you consider yourself: please circle 
 
Sedentary  lightly active  moderately active  highly active 
 
 
How long (years) have you been consistently training? 
 
 
 
Overall, how many days are you active each week? 
 
 
Besides those listed, are there any other types of activities do you participate in on a regular 
basis?  How much time do you spend each week in these activities? 
 
 
 
Please describe your average typical weekly workout schedule over the last six months (i.e. 
types of workouts/amount per day) 
 
 
 
 
When was the last time you had an injury that stopped you from exercising for more than 
three days, and what was the injury? 
 
 
 
How long were you injured? 
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Department of Exercise and Sport Science 
Medical History 
 
Subject:__________________________ ID: ___________  Telephone:______________ 
 
Address:________________________________________________________________ 
 
Occupation:___________________________________  Age:______________________ 
 
          YES NO 
Patient History 
1. How would you describe your general health at present? 
Excellent______ Good_______ Fair______ Poor______ 
2.   Do you have any health problems at the present time?   _____ _____ 
3.  If yes, please describe:         
             
4.  Have you ever been told you have heart trouble?    _____ _____ 
5.  If yes, please describe:         
             
6.  Do you ever get pain in your chest?     _____ _____ 
7.  Do you ever feel light-headed or have you ever fainted?   _____ _____ 
8.  If yes, please describe:         
             
9.  Have you ever been told that your blood pressure has been elevated? _____ _____ 
10.  If yes, please describe:         
             
11.  Have you ever had difficulty breathing either at rest or with exertion? _____ _____ 
12.  If yes, please describe:         
             
13.  Are you now, or have you been in the past 5 years, under a doctor’s care for any reason?
          _____ _____ 
14.  If yes for what reason?         
             
15.  Have you been in the hospital in the past 5 years?   _____ _____ 
16.  If yes, for what reason?         
             
17.  Have you ever experienced an epileptic seizure or been informed that you have epilepsy?
          _____ _____ 
18.  Have you ever been treated for infectious mononucleosis, hepatitis, pneumonia, or 
another infectious disease during the past year?    _____ _____ 
19.  If yes, name the disease:          
20.  Have you ever been treated for or told you might have diabetes? _____ _____  
21.  Have you ever been treated for or told you might or low blood sugar? _____ _____ 
22.  Do you have any known allergies to drugs?    _____ _____ 
23.  If so, what?          
             
 66 
24.  Have you ever been “knocked-out” or experienced a concussion? _____ _____ 
25.  If yes, have you been “knocked-out” more than once?   _____ _____ 
26.  Have you ever experienced heat stroke or heat exhaustion?  _____ _____ 
27.  If yes, when?          
             
28.  Have you ever had any additional illnesses or operations? (Other than childhood 
diseases)         _____ _____ 
29.  If yes, please indicate specific illness or operations:     
             
30.  Are you now taking any pills or medications?    _____ _____ 
31.  If yes, please list:          
             
32.  Have you had any recent (within 1 year) difficulties with your: 
 a.  Feet        _____ _____ 
 b.  Legs        _____ _____ 
 c.  Back        _____ _____ 
 
Family History 
33.  Has anyone in your family (grandparent, father, mother, and/or sibling) experienced any 
of the following? 
 a.  Sudden death       _____ _____ 
 b.  Cardiac disease       _____ _____ 
 c.  Marfan’s syndrome      _____ _____ 
 
Mental History 
34.  Have you ever experienced depression?     _____ _____ 
35.  If yes, did you seek the advice of a doctor?    _____ _____ 
36.  Have you ever been told you have or has a doctor diagnosed you with panic disorder, 
obsessive-compulsive disorder, clinical depression, bipolar disorder, or any other 
psychological disease?       _____ _____ 
37.  If yes, please list condition and if you are currently taking any medication. 
Condition      Medication 
            
            
             
 
Bone and Joint History 
34.  Have you ever been treated for Osgood-Schlatter’s disease?  _____ _____ 
35.  Have you ever had any injury to your neck involving nerves or  
vertebrae?         _____ _____ 
36.  Have you ever had a shoulder dislocation, separation, or other injury of the shoulder that 
incapacitated you for a week or longer?     _____ _____ 
37.  Have you ever been advised to or have you had surgery to correct a shoulder condition?
          _____ _____ 
38.  Have you ever experienced any injury to your arms, elbows, or wrists?_____ _____ 
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39.  If yes, indicate location and type of injury:      
             
40.  Do you experience pain in your back?     _____ _____ 
41.  Have you ever had an injury to your back?    _____ _____ 
42.  If yes, did you seek the advice of a doctor?    _____ _____ 
43.  Have you ever been told that you injured the ligaments or cartilage of either knee joint?
          _____ _____ 
44.  Do you think you have a trick knee?     _____ _____ 
45.  Do you have a pin, screw, or plate somewhere in your body as the result of bone or joint 
surgery that presently limits your physical capacity?    _____ ____ 
46.  If yes, indicate where:         
             
47.  Have you ever had a bone graft or spinal fusion?   _____ _____ 
 
Activity History 
48.  During your early childhood (to age 12) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
49.  During your adolescent years (age 13-18) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
50.  Did you participate in: 
a. Intramural school sports?      _____ _____ 
b. Community sponsored sports?     _____ _____ 
c. Varsity school sports?      _____ _____ 
d. Active family recreation?      _____ _____ 
51.  Since leaving high school, how active have you been? 
 Very active ____ Quite active____  Active____  Inactive____ 
52.  Do you participate in any vigorous activity at present?   _____ _____ 
53.  If yes, please list: 
Activity  Frequency   Duration  Intensity 
            
            
            
             
54.  How would you describe your present state of fitness? 
Excellent_____ Good_____ Fair_____ Poor_____ 
55.  Please list the type(s) of work you have been doing for the previous ten years: 
Year  Work    Indoor/Outdoor Location (city/state) 
            
            
            
            
             
56.  Whom shall we notify in case of emergency? 
 Name:            
 Phone: (Home)     (Work)     
 Address:           
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57.  Name and address of personal physician:      
            
             
 
All of the above questions have been answered completely and truthfully to the best of my 
knowledge. 
 
Signature:        Date:     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examination status:  Approved  Disapproved 
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Department of Exercise & Sport Science 
Physical Examination Screening 
 
 
Name: ________________________  ID: ______   Age: _____ Gender: _____ 
 
Please respond to each of the following in writing. 
 
 
Pulse rate and regularity: ________________  ECG Interpretation: _____________ 
 
Blood Pressure: 
 
Supine: __________   Sitting: __________  Standing (Left side):   __________ 
 
Squat: ____________    Standing (Right side): ___________ 
 
Marfan Syndrome evaluation: (∆ BP, Physical Char.) ____________________________ 
 
 
Palpation of Pulses:  Carotid: __________  Radial: __________  Pedal: __________ 
 
Auscultation of the Lungs: 
 
Back:   Lower: __________ Middle: __________ Upper: __________ 
 
Front:      Middle: __________ Upper: __________ 
 
Auscultation of Heart Sounds:(Supine, Standing, Squatting) 
 
Non-Specific HS: _____  /______  /_____ 
 
Murmur: ____  Gallop: ____ Click: ___ Rub: ___ Click w/ Murmur: __ 
 
 
Bruits:  Carotid: _________ Abdominal: _________ 
 
Edema:  Abdominal: _________  Calf: _________ Pedal: ______ 
 
Tenderness:  Abdominal: _________  Other: __________ 
 
Xanthoma or xanthelasm: __________ 
 
 
Medical / Family History: 
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High Blood Pressure: __________ Diabetes: _________  CHD/CAD: _______ 
  
Last examination w/ physician: ___________ 
 
Medications (prescription / counter): __________________________________________ 
 
 
 
Examiner: _____________________________________  Date: _____________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C 
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Quantikine HS, Human TNF-α/TNFSF1A Immunoasasay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright held by R&D Systems, Inc. 
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